<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">JIC</journal-id>
         <journal-id journal-id-type="hwp">spjic</journal-id>
         <journal-id journal-id-type="nlm-ta">J Intensive Care Med</journal-id>
         <journal-title>Journal of Intensive Care Medicine</journal-title>
         <issn pub-type="ppub">0885-0666</issn>
         <issn pub-type="epub">1525-1489</issn>
         <publisher>
            <publisher-name>SAGE Publications</publisher-name>
            <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.1177/0885066611411408</article-id>
         <article-id pub-id-type="publisher-id">10.1177_0885066611411408</article-id>
         <article-categories>
            <subj-group subj-group-type="heading">
               <subject>Analytic Reviews</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>The Management of the Critically Ill Obstetric Patient</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" corresp="yes" xlink:type="simple">
               <name name-style="western">
                  <surname>Honiden</surname>
                  <given-names>Shyoko</given-names>
               </name>
               <degrees>MD, MS</degrees>
               <xref ref-type="aff" rid="aff1-0885066611411408">1</xref>
               <xref ref-type="corresp" rid="corresp1-0885066611411408"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Abdel-Razeq</surname>
                  <given-names>Sonya S.</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="aff2-0885066611411408">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Siegel</surname>
                  <given-names>Mark D.</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="aff1-0885066611411408">1</xref>
            </contrib>
         </contrib-group>
         <aff id="aff1-0885066611411408">
            <label>1</label>Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA</aff>
         <aff id="aff2-0885066611411408">
            <label>2</label>Gynecology and Reproductive Sciences, Division of Maternal–Fetal Medicine, Department of Obstetrics and Gynecology &amp; Division of Surgical Critical Care, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA</aff>
         <author-notes>
            <corresp id="corresp1-0885066611411408">Shyoko Honiden, Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208057, New Haven, CT 06520, USA. Email: <email xlink:type="simple">shyoko.honiden@yale.edu</email>
            </corresp>
         </author-notes>
         <pub-date pub-type="epub-ppub">
            <month>3</month>
            <year>2013</year>
         </pub-date>
         <volume>28</volume>
         <issue>2</issue>
         <fpage>93</fpage>
         <lpage>106</lpage>
         <permissions>
            <copyright-statement>© The Author(s) 2011</copyright-statement>
            <copyright-year>2011</copyright-year>
            <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
         </permissions>
         <abstract>
            <p>Hypertensive disorders, postpartum hemorrhage, and sepsis are the most common indications for intensive care unit admission among obstetric patients. In general, ICU mortality is low, and better than would be predicted using available mortality prediction tools. Provision of care to this special population requires an intimate understanding of physiologic changes that occur during pregnancy. Clinicians must be aware of the way various diagnostic and treatment choices can affect the mother and fetus. Most clinically necessary radiographic tests can be safely performed and fall under the maternal radiation exposure limit of less than 0.05 Gray (Gy). Careful attention must be paid to acid–base status, oxygenation, and ventilation when faced with respiratory failure necessitating intubation. Cesarean delivery can be justified after 4 minutes of cardiac arrest and may improve fetal and maternal outcomes. The treatment of obstetric patients in the ICU introduces complexities and challenges that may be unfamiliar to many critical care physicians; teamwork and communication with obstetricians is crucial.</p>
         </abstract>
         <kwd-group>
            <kwd>critical illness</kwd>
            <kwd>pregnancy</kwd>
            <kwd>eclampsia</kwd>
            <kwd>postpartum hemorrhage</kwd>
            <kwd>sepsis</kwd>
            <kwd>acute respiratory distress syndrome</kwd>
         </kwd-group>
         <custom-meta-wrap>
            <custom-meta xlink:type="simple">
               <meta-name>cover-date</meta-name>
               <meta-value>March/April 2013</meta-value>
            </custom-meta>
         </custom-meta-wrap>
      </article-meta>
   </front>
   <body>
      <sec id="section1-0885066611411408">
         <title>Introduction</title>
         <p>The overwhelming majority of pregnant women enjoy an uneventful pregnancy with the birth of a healthy baby. Obstetric patients account for only a small percentage of intensive care unit (ICU) admissions, with estimates ranging from 0.3% to 1.8%.<sup>
               <xref ref-type="bibr" rid="bibr1-0885066611411408">1</xref>
               <xref ref-type="bibr" rid="bibr2-0885066611411408"/>–<xref ref-type="bibr" rid="bibr3-0885066611411408">3</xref>
            </sup> Pregnancy-related abnormalities, particularly hypertensive disorders, postpartum hemorrhage, and sepsis, are the most common reasons for ICU admission.<sup>
               <xref ref-type="bibr" rid="bibr3-0885066611411408">3</xref>
               <xref ref-type="bibr" rid="bibr4-0885066611411408"/>
               <xref ref-type="bibr" rid="bibr5-0885066611411408"/>–<xref ref-type="bibr" rid="bibr6-0885066611411408">6</xref>
            </sup> Intensive care unit mortality is generally lower than severity of illness scores such as the Acute Physiologic and Chronic Health Evaluation score (APACHE) would predict—less than 5% in most series.<sup>
               <xref ref-type="bibr" rid="bibr1-0885066611411408">1</xref>,<xref ref-type="bibr" rid="bibr5-0885066611411408">5</xref>,<xref ref-type="bibr" rid="bibr7-0885066611411408">7</xref>
               <xref ref-type="bibr" rid="bibr8-0885066611411408"/>–<xref ref-type="bibr" rid="bibr9-0885066611411408">9</xref>
            </sup>
         </p>
         <p>The management of critically ill obstetric patients introduces unique challenges. When caring for pregnant patients, the well-being of both the fetus and the mother must be considered and sometimes balanced against each other. Physicians need to familiarize themselves with important physiologic changes that accompany pregnancy that can impact critical illness. Unfortunately many evidence-based ICU guidelines are difficult to extrapolate because ICU studies often exclude pregnant women. Certain critical illnesses are unique or may be more dangerous during pregnancy, an example being respiratory failure associated with the recent pandemic H1N1 influenza A.<sup>
               <xref ref-type="bibr" rid="bibr10-0885066611411408">10</xref>,<xref ref-type="bibr" rid="bibr11-0885066611411408">11</xref>
            </sup> Optimal care requires ICU physicians to work closely with obstetricians, which in many centers includes maternal–fetal medicine specialists. Finally, attention must be paid to potential consequences of ICU-based interventions and tests, as well as to difficult ethical challenges that may arise while treating this special population.</p>
         <p>In subsequent sections, we will review (1) the changing demographics of the critically ill obstetric patient, (2) physiologic changes that occur in pregnancy that are relevant to the ICU, (3) ICU-based testing and interventions and their potential impact on the mother and fetus, (4) common ICU diagnoses, and (5) ethical challenges pertaining to the pregnant patient.</p>
      </sec>
      <sec id="section2-0885066611411408">
         <title>Epidemiology</title>
         <p>The need for ICU care is infrequent during the peripartum period. Incidence estimates vary between series depending on the definitions used, years studied, sample size, and geographic location. Critical illness complicates less than 1% of all pregnancies.<sup>
               <xref ref-type="bibr" rid="bibr1-0885066611411408">1</xref>,<xref ref-type="bibr" rid="bibr3-0885066611411408">3</xref>,<xref ref-type="bibr" rid="bibr5-0885066611411408">5</xref>,<xref ref-type="bibr" rid="bibr7-0885066611411408">7</xref>
               <xref ref-type="bibr" rid="bibr8-0885066611411408"/>–<xref ref-type="bibr" rid="bibr9-0885066611411408">9</xref>,<xref ref-type="bibr" rid="bibr12-0885066611411408">12</xref>,<xref ref-type="bibr" rid="bibr13-0885066611411408">13</xref>
            </sup> Obstetric complications, particularly during the postpartum period, account for most ICU admissions. Hypertensive disorders (preeclampsia and eclampsia) and postpartum hemorrhage top the list. Worse outcomes occur in ethnic minorities, recent immigrants, and those with lower socioeconomic status.</p>
         <p>Complications from preexisting medical conditions are emerging as an important cause of morbidity and mortality. With improvements in general medical care, more women with chronic illness are surviving to childbearing age. Many once deemed incapable of successfully carrying a pregnancy to term now do, particularly as reproductive technology and high-risk pregnancy care have become more sophisticated. Increasingly, many women in developed countries are becoming pregnant for the first time at an older age. US census data show that the number of first births per 1000 women aged 30 to 34 increased by 14% between 1990 and 2006. The same statistic for women between the ages of 35 and 39 rose by 48.5%. The birth rate<sup>
               <xref ref-type="bibr" rid="bibr14-0885066611411408">14</xref>
            </sup> among women aged 40 to 44 increased by 53% from 1990 to 2004.</p>
         <p>The obesity pandemic in developed countries has had an important impact on pregnancy-related complications. Higher pregravid body mass index is an important risk factor for hypertensive disorders (which is the leading cause of ICU admission in most series), need for cesarean section (which itself is associated with postpartum hemorrhage), and morbidity from obstetric anesthesia (which include difficult airways and failed intubations).<sup>
               <xref ref-type="bibr" rid="bibr15-0885066611411408">15</xref>
            </sup> In the United States, prevalence estimates<sup>
               <xref ref-type="bibr" rid="bibr16-0885066611411408">16</xref>
            </sup> for obesity among pregnant women varies from 18.5% to 35.3%. One study<sup>
               <xref ref-type="bibr" rid="bibr17-0885066611411408">17</xref>
            </sup> showed that the prevalence of prepregnancy obesity, defined as a body mass index greater than 29 kg/m<sup>
               <xref ref-type="bibr" rid="bibr2-0885066611411408">2</xref>
            </sup>, increased from 13% to 22% between 1993 and 2003. The growing prevalence of obesity is likely to increase the number of patients admitted to the ICU with pregnancy-related complications for many years to come.</p>
      </sec>
      <sec id="section3-0885066611411408">
         <title>Prognosis and Predicting Mortality</title>
         <p>Maternal mortality among patients admitted to the ICU is less than 5% and usually clusters between 2% and 3% in most series.<sup>
               <xref ref-type="bibr" rid="bibr1-0885066611411408">1</xref>,<xref ref-type="bibr" rid="bibr5-0885066611411408">5</xref>,<xref ref-type="bibr" rid="bibr7-0885066611411408">7</xref>
               <xref ref-type="bibr" rid="bibr8-0885066611411408"/>–<xref ref-type="bibr" rid="bibr9-0885066611411408">9</xref>
            </sup> Commonly used prognostic scoring tools such as APACHE II and III typically overestimate maternal mortality, particularly if the ICU admission is the result of a pregnancy-specific disorder. Several factors explain this overestimate. First, available scoring tools were not specifically developed with the gravid patient in mind. Many physiological variables that deviate from “normal” may contribute to a higher severity of illness score, even though these variables are generally expected in pregnancy, such as respiratory alkalosis, higher heart rate, higher respiratory rate, lower blood pressure, or laboratory changes such as a lower hematocrit. In contrast, other abnormalities, such as evidence of hemolysis, elevated liver enzymes, and low platelet counts, which are hallmarks of the hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome, are not routinely included in the evaluation. Second, despite life-threatening derangements and organ dysfunction, many obstetric-specific disorders such as preeclampsia and acute fatty liver of pregnancy have a unique therapeutic modality not available to other critically ill patients—that is, the disease often resolves quickly and completely with delivery of the fetus.</p>
      </sec>
      <sec id="section4-0885066611411408">
         <title>Cardiopulmonary Changes in Pregnancy</title>
         <sec id="section5-0885066611411408">
            <title>Cardiovascular</title>
            <p>Important physiological changes occur with different stages of pregnancy. Normal cardiovascular changes can mimic sepsis with relative peripheral vasodilation and low blood pressure, increased heart rate, and high cardiac output. During pregnancy, lower systemic blood pressure results from relaxed vasomotor tone mediated by prostacyclin, nitric oxide, and other gestational hormones. Blood pressure is lowest halfway through a normal pregnancy and slowly returns to prepregnant baseline near term. Cardiac output may increase by up to 50% via increases in heart rate and stroke volume. Although some variability exists between studies with regard to timing of hemodynamic changes during pregnancy due to technical differences, in general, changes in cardiac output start early, at approximately 10 weeks of gestation, and peak around the end of the second trimester.<sup>
                  <xref ref-type="bibr" rid="bibr18-0885066611411408">18</xref>,<xref ref-type="bibr" rid="bibr19-0885066611411408">19</xref>
               </sup> Early rise in cardiac output is driven by the significant increase in preload as well as changes in stroke volume and heart rate. Later on, cardiac output is primarily maintained by the increased heart rate. The uterus and the conception products receive up to a third of the augmented cardiac output—uterine blood flow increases from 50 to 500 mL/min at term. Heart rate typically reaches and stays at 120% of baseline values by 32 weeks. In the context of these changes, further loss of vasomotor tone and myocardial depression during pregnancy-associated sepsis can cause dramatic decreases in blood pressure and perfusion.</p>
            <p>Pregnancy is associated with an average 1200 mL increase in maternal blood volume,<sup>
                  <xref ref-type="bibr" rid="bibr20-0885066611411408">20</xref>
               </sup> which increases the preload and helps augment cardiac output. Blood volume peaks at 40% above baseline during the third trimester. Plasma volume increases disproportionally to red cell mass, leading to a dilutional anemia and fall in plasma oncotic pressure. Colloid oncotic pressure decreases from 23.2 mm Hg in the first trimester to 21.1 mm Hg at term, and further drops to 16 mm Hg after delivery. This postpartum decline can be even more pronounced in patients with preeclampsia. Decreased colloid oncotic pressure predisposes patients to pulmonary edema even in the absence of elevated hydrostatic pressures, and particular attention is needed during volume resuscitation in shock.<sup>
                  <xref ref-type="bibr" rid="bibr21-0885066611411408">21</xref>
               </sup>
            </p>
            <p>There are additional cardiovascular changes that occur during labor, delivery, and in the postpartum period. Preload increases during labor, as blood from the uterine sinusoids are “autotransfused” and released into the systemic circulation (as much as 300-500 mL) with each uterine contraction. Cardiac output increases about 15% during early labor and up to 25% during the active phase. During active pushing and exertion in the second stage of labor, cardiac output may increase further, up to 50% above prelabor values. Finally, immediately postpartum, cardiac output may increase as much as 80% due to increases in preload related to further autotransfusion as the uterus involutes and the mechanical compression of the vena cava is relieved. Meanwhile blood pressure increases significantly as well (systolic pressure rises by about 20%) with each contraction. During the second stage of labor, the blood pressure and heart rate fluctuations mirror that seen during a Valsalva maneuver. Hemodynamic normalization takes place over days to weeks postpartum.<sup>
                  <xref ref-type="bibr" rid="bibr22-0885066611411408">22</xref>
               </sup>
            </p>
            <p>The uteroplacental circulation lacks autoregulatory mechanisms and the uteroplacental vessels are maximally vasodilated at baseline. When the maternal circulation is compromised and compensatory vasoconstriction occurs, uteroplacental perfusion can be dramatically reduced and lead to fetal hypoxia. Therefore, fetal distress, manifesting as fetal bradycardia, may portend impending maternal deterioration. Historically, on the basis of limited animal data, ephedrine has been described as the agent of choice when vasopressor support is required.<sup>
                  <xref ref-type="bibr" rid="bibr23-0885066611411408">23</xref>
               </sup> Agents more typically used to treat shock, such as epinephrine, norepinephrine, dopamine, and phenylephrine, all carry some risk of inducing vasoconstriction in the uterine blood vessels. Excepting a few animal studies however, none of them have been rigorously studied in humans and nearly all studies comparing different vasopressors were performed in the context of transient hypotension encountered during spinal anesthesia for elective cesarean section. Therefore, there is inadequate evidence to make pregnancy-specific vasopressor recommendations. For example, one meta-analysis comparing phenylephrine to ephedrine showed that they were equally effective at correcting maternal hypotension induced by spinal anesthesia.<sup>
                  <xref ref-type="bibr" rid="bibr24-0885066611411408">24</xref>
               </sup> Neonatal Apgar scores and the incidence of significant fetal acidosis (pH &lt; 7.2) were similar, but phenylephrine caused more bradycardia. Anecdotally, all agents used routinely for hemodynamic support in the ICU have been successfully used in pregnant women. In almost all cases, improving the status of the mother parallels favorable fetal outcome. Vasopressor choice therefore, must consider the underlying etiology of shock as in nonpregnant patients and balance potential improvements in other parameters, such as cardiac output (eg, with the use of agents with β-agonist activity during septic shock) against the potential concerns regarding the effect on uteroplacental circulation. When instituting early goal-directed therapy for sepsis, clinicians need to be mindful of normal changes in hemodynamic parameters associated with pregnancy. For example, central venous saturations may be as high as 80% during pregnancy.<sup>
                  <xref ref-type="bibr" rid="bibr25-0885066611411408">25</xref>
               </sup>
            </p>
            <p>Late in pregnancy, the inferior vena cava may be nearly completely obstructed in the supine position. Venous return occurs via collateral circulation through azygous, lumbar, and paraspinal veins. From the second trimester onward, patients with evidence of hemodynamic compromise or those with signs of poor organ perfusion should be placed in the left lateral decubitus position as much as possible to counter this compressive effect, as cardiac output may improve as much as 20% to 30% by this simple maneuver.</p>
         </sec>
         <sec id="section6-0885066611411408">
            <title>Respiratory</title>
            <p>Pregnant patients undergo a number of respiratory adaptations, some of which place the patient at risk for respiratory compromise during critical illness. Progesterone stimulates an approximate 30% increase in minute ventilation, achieved by an increase in tidal volume. In the meantime, respiratory rate does not change significantly.<sup>
                  <xref ref-type="bibr" rid="bibr19-0885066611411408">19</xref>
               </sup> P<sc>co</sc>
               <sub>2</sub> drops to the 28 to 32 mm Hg range; with renal compensation, the arterial pH is maintained between 7.40 and 7.47. Thus, a seemingly minor increase in P<sc>co</sc>
               <sub>2</sub> above 40 mm Hg may reflect significant respiratory compromise in pregnancy. Partial pressure of oxygen in arterial blood (Pa<sc>o</sc>
               <sub>2</sub>) is generally slightly increased to an average of 100 to 105 mm Hg at sea level. Pregnant women have reduced capacity for respiratory compensation in response to a metabolic acidosis. The diaphragm may migrate upward by up to 4 cm, reducing functional residual capacity by 10% to 20%. Increases in chest wall circumference, widening of the costal angle, as well as elevation of the diaphragm start even before significant increases in uterine size, maternal body weight or intra-abdominal Pressure. Relaxation of ligamentous attachments due to the hormonal effects of relaxin appear to play an important role. Oxygen consumption increases by 20% to 33% due to increased maternal metabolism and to meet the needs of the growing conception products. All of these changes translate to an overall reduced respiratory reserve and place the pregnant women at risk of precipitous drops in oxygenation during critical illness.</p>
         </sec>
      </sec>
      <sec id="section7-0885066611411408">
         <title>Consequences of ICU-Based Interventions, Tests, and Medications</title>
         <sec id="section8-0885066611411408">
            <title>Intubation and Mechanical Ventilation</title>
            <p>Reductions in functional residual capacity and increased oxygen consumption predispose patients to rapid desaturation and make adequate preoxygenation for intubation difficult. In a Korean study, pregnant patients admitted for an elective cesarean section were compared to matched nonpregnant controls admitted for other gynecologic surgery.<sup>
                  <xref ref-type="bibr" rid="bibr26-0885066611411408">26</xref>
               </sup> Both groups were sedated, paralyzed, preoxygenated with 100% oxygen and intubated. Subsequently, patients were subjected to 1 episode of apnea while changes in oxygen saturation and carbon dioxide levels were monitored. In pregnant patients, carbon dioxide rose nearly 2½ times faster (6.8 ± 1.8 vs 2.8 ± 1.2 mm Hg per minute), and desaturation from 100% to 90% occurred twice as quickly (3.6 ± 0.8 vs 7.5 ± 0.9 minutes).</p>
            <p>When severe hypoxemic respiratory failure necessitates intubation, slowed gastrointestinal motility, progesterone-mediated loss of lower esophageal sphincter tone, and the higher intra-abdominal pressures from the gravid uterus increase the risk of peri-intubation aspiration. Patients should be kept semi-recumbent while preparing for intubation to reduce compression of the inferior vena cava and to decrease pressure on the diaphragm. Pregnancy predisposes patients to airway mucosal edema and friability, and this can obscure visualization and increase the risk of trauma and bleeding during intubation. In some series, failed intubation was increased 8-fold in pregnancy compared to the general population.<sup>
                  <xref ref-type="bibr" rid="bibr27-0885066611411408">27</xref>
               </sup> Patients with preeclampsia may be at particular risk, because of pronounced mucosal edema due to a low oncotic pressure state that in turn leads to a relatively smaller upper airway caliber,<sup>
                  <xref ref-type="bibr" rid="bibr28-0885066611411408">28</xref>
               </sup> as well as higher risk of bleeding from possible concurrent thrombocytopenia.</p>
            <p>The use of lung protective, low tidal volume ventilation for patients with acute respiratory distress syndrome (ARDS) has not been well studied in pregnant women. Reduced chest wall compliance, particularly in late pregnancy, may raise airway pressures beyond typically accepted limits (eg, plateau pressures of 30 cm H<sub>2</sub>O) even in the absence of dangerous transpulmonary pressures.<sup>
                  <xref ref-type="bibr" rid="bibr29-0885066611411408">29</xref>
               </sup> However, lung injury itself is likely to contribute more significantly to the decreased compliance in pregnant patients with ARDS; therefore, it is reasonable to adopt the ARDS Network’s lung protective strategy without specific modifications.<sup>
                  <xref ref-type="bibr" rid="bibr30-0885066611411408">30</xref>
               </sup>
            </p>
            <p>When setting tidal volumes, the nonpregnant predicted ideal body weight should be used. It is not clear whether maintenance of the mild respiratory alkalosis characteristic of pregnancy is absolutely necessary. Severe respiratory alkalosis should be avoided because this can promote uterine vasoconstriction and adversely affect uterine blood flow.<sup>
                  <xref ref-type="bibr" rid="bibr31-0885066611411408">31</xref>
               </sup> Under normal conditions, maternal–fetal CO<sub>2</sub> gradient is around 10 to 13 mm Hg. This gradient, as well as adequate blood flow at both sides of the placenta must be preserved to facilitate diffusion of carbon dioxide from fetus to mother. One case report has suggested that permissive hypercapnia (up to a P<sc>co</sc>
               <sub>2</sub> of 60 mm Hg) can be acceptable, provided adequate oxygenation is maintained.<sup>
                  <xref ref-type="bibr" rid="bibr32-0885066611411408">32</xref>
               </sup> Limited data from high-risk neonates suggest that moderate elevations of P<sc>co</sc>
               <sub>2</sub> (between 45 and 55 mm Hg) are well tolerated in the newborn.<sup>
                  <xref ref-type="bibr" rid="bibr33-0885066611411408">33</xref>
               </sup> The exact consequence of hypercapnia on the fetus is difficult to know. The effects likely vary from fetus to fetus and may depend on duration and degree of hypercapnea, developmental stage of fetus, and other concurrent insults to the fetus during critical illness in the mother. Under experimental conditions in a normal pregnancy near term, transient elevations of P<sc>co</sc>
               <sub>2</sub> (up to 60 mm Hg, mean duration 3.9 minutes) had no significant effect on fetal heart rate but appeared to diminish heart rate variability.<sup>
                  <xref ref-type="bibr" rid="bibr34-0885066611411408">34</xref>
               </sup> Other studies have shown variable effects on other indices of fetal well-being, such as changes in cerebral blood flow and fetal breathing movements.<sup>
                  <xref ref-type="bibr" rid="bibr35-0885066611411408">35</xref>
               </sup> In the context of ARDS, the use of a lung protective strategy that accepts permissive hypercapnea has been shown in a large randomized study to have robust morbidity and mortality improvements.<sup>
                  <xref ref-type="bibr" rid="bibr29-0885066611411408">29</xref>
               </sup> This real benefit to the mother is hard to deny, despite the concerns regarding potential risk to the fetus. As noted earlier, it is reassuring to note that optimizing maternal outcome ultimately ensures fetal well-being in most circumstances.</p>
            <p>Acid–base status should be monitored closely because acidemia can undermine oxygen delivery in the fetus. It is important to recognize that diffusion of ions, such as bicarbonate, across the placenta is slow, and simple infusion of bicarbonate-based solutions to the mother may not reliably correct fetal acidemia. Under normal circumstances, oxygen-carrying capacity in the fetal circulation is supported by the fact that fetal hemoglobin is more avid for oxygen at any given Pa<sc>o</sc>
               <sub>2</sub> compared to adult hemoglobin, represented by a shift of the oxygen dissociation curve to the left. For example, oxygen saturation may be between 80% and 90%, when the Pa<sc>o</sc>
               <sub>2</sub> is only 30 to 35 mmHg in the umbilical vein. In the setting of acidosis, as might occur with permissive hypercapnia, a rightward shift in the hemoglobin–oxygen dissociation curve could reduce oxygen-carrying capacity in the fetal circulation. Fetal oxygen saturation is also dependent on adequate placental flow, and transfer of oxygen across the placenta is driven by oxygen content. In sum, ventilator settings should generally be adjusted to ensure maternal oxygen saturations above 95% (or Pa<sc>o</sc>
               <sub>2</sub> of 70 mmHg),<sup>
                  <xref ref-type="bibr" rid="bibr36-0885066611411408">36</xref>
               </sup> to avoid large deviations in acid–base status, and to prevent excessive elevations in P<sc>co</sc>
               <sub>2</sub> as much as possible. A goal maternal Pa<sc>co</sc>
               <sub>2</sub> of &lt;45 mmHg, which corresponds to a maternal pH of &gt;7.30 (assuming there is no concurrent metabolic disarray), is a reasonable target for pregnant women, but this may not always be feasible or safely accomplished, particularly in cases of severe asthma and ARDS. Although data are limited, it appears that higher levels of carbon dioxide may be tolerated by the fetus.<sup>
                  <xref ref-type="bibr" rid="bibr30-0885066611411408">30</xref>
               </sup> Compared to the typical patient with respiratory failure in the ICU, more frequent arterial blood gas measurements are warranted, so that trends in Pa<sc>o</sc>
               <sub>2</sub>, P<sc>co</sc>
               <sub>2</sub>, and pH can be monitored carefully.</p>
            <p>In desperate circumstances where the usual ventilator strategies fail to improve ventilation and oxygenation, alternative rescue modes of ventilation are often attempted in nonpregnant patients. There is a paucity of literature on the use of such modes during pregnancy, although a recent case series showed successful application of airway pressure release ventilation (APRV)<sup>
                  <xref ref-type="bibr" rid="bibr37-0885066611411408">37</xref>
               </sup> and prone positioning.<sup>
                  <xref ref-type="bibr" rid="bibr38-0885066611411408">38</xref>
               </sup> Wider clinical experience was also gained during the 2009 H1N1 influenza pandemic. Reduced chest wall compliance during pregnancy compounded by low lung compliance from lung injury may result in severe lung derecruitment when low tidal volumes are used. The use of higher positive end-expiratory pressure (PEEP) which is often employed in nonpregnant patients with severe ARDS may not be well tolerated hemodynamically.<sup>
                  <xref ref-type="bibr" rid="bibr39-0885066611411408">39</xref>
               </sup> High PEEP and resultant elevations in intrathoracic pressure may restrict venous return into the thorax, thereby negating the adaptive high cardiac output state seen during pregnancy. Hirani and colleagues<sup>
                  <xref ref-type="bibr" rid="bibr37-0885066611411408">37</xref>
               </sup> postulated that APRV, which allows for higher mean airway pressures and a short release time, may help recruit atelectatic lung tissue while avoiding overdistention—but at present, there are insufficient data to suggest that this mode of ventilation is superior to the use of high PEEP, as in the ARDSNet strategy.</p>
            <p>Data regarding the impact of fetal delivery on maternal oxygenation and ventilation are mixed. In one series, delivery in 9 patients reduced oxygen requirements by 28%, but clinical outcomes were unchanged.<sup>
                  <xref ref-type="bibr" rid="bibr40-0885066611411408">40</xref>
               </sup> Other groups have not shown benefit. For example, of the 5 patients who underwent delivery while on mechanical ventilation, only 1 had a dramatic improvement in oxygenation postpartum.<sup>
                  <xref ref-type="bibr" rid="bibr41-0885066611411408">41</xref>
               </sup> If refractory hypoxemia cannot be reversed, and if the fetus is viable, one might also argue a theoretical benefit to the fetus with expeditious delivery. However, fetal and maternal mortality and morbidity are higher for cesarean sections in emergency settings, and the physiologic stress of operative delivery must be carefully weighed against the perceived benefit to the mother and fetus. Given lack of convincing data, delivery should be performed applying standard obstetric indications. For example, if the underlying etiology of respiratory failure relates to pulmonary edema due to severe preeclampsia, delivery is a proven treatment that improves outcomes. On the other hand, physiologic compromise due to other causes, such as preexisting valvular heart disease, may potentially worsen during labor and delivery, as the dramatic hemodynamic changes that occur may not be well tolerated.</p>
         </sec>
         <sec id="section9-0885066611411408">
            <title>Diagnostic Imaging and Radiation Exposure</title>
            <p>In general, ionizing radiation associated with diagnostic imaging tests should be minimized to the extent that it can be done safely. This is especially true during the first trimester when the teratogenic and oncogenic risks to the fetus are highest. Particular attention should be paid between weeks 2 to7 postconception when organogenesis is occurring. Most clinically necessary tests, however, can be safely performed, provided abdominal shields are used and well-collimated beams are utilized to minimize scatter. Maternal radiation exposure of less than 0.05 Gray (Gy) is generally safe, with no documented teratogenic effects (congenital abnormalities) in any trimester. Some authors have suggested that beyond 16 weeks of conception, the threshold dose for teratogenic effects may be closer to 0.50 to 0.70 Gy.<sup>
                  <xref ref-type="bibr" rid="bibr42-0885066611411408">42</xref>
               </sup> In contrast, prenatal radiation exposure at any dose may be associated with an increased risk of childhood malignancy, particularly leukemia<sup>
                  <xref ref-type="bibr" rid="bibr43-0885066611411408">43</xref>
               </sup> (<xref ref-type="table" rid="table1-0885066611411408">Table 1</xref>
). <xref ref-type="table" rid="table2-0885066611411408">Table 2</xref>
lists approximate fetal radiation doses for common radiologic procedures.</p>
            <table-wrap id="table1-0885066611411408" position="float">
               <label>Table 1.</label>
               <caption>
                  <p>Noncancer and Cancer-Related Risk Estimates From Prenatal Radiation Exposure.<sup>
                        <xref ref-type="table-fn" rid="table-fn1-0885066611411408">a</xref>
                     </sup>
                  </p>
               </caption>
               <graphic alt-version="no" alternate-form-of="table1-0885066611411408" position="float" xlink:href="10.1177_0885066611411408-table1.tif" xlink:type="simple"/>
               <table>
                  <thead>
                     <tr>
                        <th colspan="2" rowspan="1">&lt;0.05 Gray (Gy) = no documented teratogenic effects (congenital abnormalities) in any trimester</th>
                     </tr>
                     <tr>
                        <th colspan="1" rowspan="1">Radiation dose (Gy)</th>
                        <th align="center" colspan="1" rowspan="1">Estimated childhood cancer incidence (%)</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">No more than background</td>
                        <td colspan="1" rowspan="1">0.3</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">0-0.05</td>
                        <td colspan="1" rowspan="1">0.3-1</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">0.05-0.50</td>
                        <td colspan="1" rowspan="1">1-6</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">&gt;0.50</td>
                        <td colspan="1" rowspan="1">&gt;6</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn id="table-fn1-0885066611411408">
                     <p>
                        <sup>a</sup> Data adapted from Centers for Disease Control and Prevention. Radiation and pregnancy: a fact sheet for clinicians. <ext-link ext-link-type="uri" xlink:href="http://www.bt.cdc.gov/radiation/prenatalphysician.asp.43" xlink:type="simple">http://www.bt.cdc.gov/radiation/prenatalphysician.asp.43</ext-link>.</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <table-wrap id="table2-0885066611411408" position="float">
               <label>Table 2.</label>
               <caption>
                  <p>Estimated Fetal Radiation Doses From Common Diagnostic Imaging Tests.<sup>
                        <xref ref-type="table-fn" rid="table-fn3-0885066611411408">a</xref>
                     </sup>
                  </p>
               </caption>
               <graphic alt-version="no" alternate-form-of="table2-0885066611411408" position="float" xlink:href="10.1177_0885066611411408-table2.tif" xlink:type="simple"/>
               <table>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1">Procedure</th>
                        <th colspan="1" rowspan="1">Fetal Dose in Gray<sup>
                              <xref ref-type="table-fn" rid="table-fn2-0885066611411408">b</xref>
                           </sup>
                        </th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="2" rowspan="1">Radiography</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Chest X-ray (2 views)</td>
                        <td colspan="1" rowspan="1">&lt;0.0001</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Abdomen</td>
                        <td colspan="1" rowspan="1">0.001-0.003</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Hip and femur</td>
                        <td colspan="1" rowspan="1">0.00051-0.00370</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Mammography</td>
                        <td colspan="1" rowspan="1">0.00007-0.00020</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Upper gastrointestinal series (barium)</td>
                        <td colspan="1" rowspan="1">0.00048-0.00360</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Barium enema or small bowel series</td>
                        <td colspan="1" rowspan="1">0.02-0.04</td>
                     </tr>
                     <tr>
                        <td colspan="2" rowspan="1">Computed tomography</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Abdomen (10 slices)</td>
                        <td colspan="1" rowspan="1">0.00240-0.0260</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Lumbar spine</td>
                        <td colspan="1" rowspan="1">0.035</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Head</td>
                        <td colspan="1" rowspan="1">&lt;0.0005</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Pelvis</td>
                        <td colspan="1" rowspan="1">0.00730-0.0460</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Chest</td>
                        <td colspan="1" rowspan="1">0.0010-0.0045</td>
                     </tr>
                     <tr>
                        <td colspan="2" rowspan="1">Other</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Ventilation–perfusion scan</td>
                        <td colspan="1" rowspan="1">0.0006-0.01</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn id="table-fn2-0885066611411408">
                     <p>
                        <sup>b</sup> To convert Gray into rad, multiply by 100.</p>
                  </fn>
                  <fn id="table-fn3-0885066611411408">
                     <p>
                        <sup>a</sup> Data obtained from Williams and Fletcher<sup>
                           <xref ref-type="bibr" rid="bibr117-0885066611411408">117</xref>
                        </sup>and ACOG Committee Opinion.<sup>
                           <xref ref-type="bibr" rid="bibr118-0885066611411408">118</xref>
                        </sup>
                     </p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <p>Concern about pulmonary embolism poses a dilemma when pregnant patients present with acute shortness of breath. Diagnostic strategies that avoid radiation should be implemented first. Although the <sc>d</sc>-dimer levels rise starting in the second trimester, a completely normal test result may be clinically useful, particularly when the pretest probability is low. Further radiographic imaging is probably unnecessary in this subset.<sup>
                  <xref ref-type="bibr" rid="bibr44-0885066611411408">44</xref>
               </sup> When lower extremity ultrasound testing reveals a thrombus, further imaging can be avoided as this is unlikely to change management—unless hemodynamic instability raises concern with regard to a massive pulmonary embolus and further invasive interventions such as thrombectomy are being entertained. The typical management challenge occurs when lower extremity ultrasound testing reveals no deep venous thrombosis, the chest x-ray is normal and careful history and physical examination afford no clear alternative explanation for dyspnea and hypoxemia. Additional diagnostic testing to investigate pulmonary embolism requires radiation and places the woman and fetus at potential risk. This includes the increasingly recognized long-term cancer risks particularly for young women of reproductive age.<sup>
                  <xref ref-type="bibr" rid="bibr45-0885066611411408">45</xref>,<xref ref-type="bibr" rid="bibr46-0885066611411408">46</xref>
               </sup> Although ventilation–perfusion scans expose the fetus to relatively small amounts of radiation, mean fetal doses may be even lower with computed tomography (CT) pulmonary angiography.<sup>
                  <xref ref-type="bibr" rid="bibr47-0885066611411408">47</xref>
               </sup> Furthermore, ventilation–perfusion scintigraphy may be indeterminate in up to 25% of patients during pregnancy, necessitating additional studies if the pretest probability is sufficiently high.<sup>
                  <xref ref-type="bibr" rid="bibr48-0885066611411408">48</xref>
               </sup> Therefore, CT pulmonary angiography is the diagnostic test of choice in most circumstances.<sup>
                  <xref ref-type="bibr" rid="bibr49-0885066611411408">49</xref>
               </sup>
            </p>
            <p>Iodine-based contrast media are classified as ionic or nonionic. The iodine content has the potential to cause thyroid dysfunction in the neonate. No definitive human data have demonstrated a link between intravenous nonionic contrast media and neonatal hypothyroidism.<sup>
                  <xref ref-type="bibr" rid="bibr50-0885066611411408">50</xref>
               </sup> A recent retrospective study reported on the neonatal outcome in approximately 350 women exposed to contrast through a CT study done at a mean gestational age of 28 weeks to rule out pulmonary embolism. Only 1 neonate demonstrated a transiently abnormal thyroid-stimulating hormone level at birth.<sup>
                  <xref ref-type="bibr" rid="bibr51-0885066611411408">51</xref>
               </sup> However, because of older literature showing that direct instillation of ionic contrast into the amniotic sac during amniofetography can indeed lead to hypothyroidism, the American College of Radiology recommends that all iodinated contrast material be administered after informed consent is obtained.<sup>
                  <xref ref-type="bibr" rid="bibr49-0885066611411408">49</xref>
               </sup> Shortly after birth, all neonates exposed to contrast in utero should have their thyroid function studies tested to rule out hypothyroidism if this is not already being performed as part of routine neonatal screening. There is a paucity of safety data as it pertains to gadolinium used for magnetic resonance imaging. Because of theoretical concerns for gadolinium-induced nephrogenic systemic fibrosis to the fetus (as gadolinium crosses the placenta and likely excreted by the fetal kidneys), the risks and benefits of gadolinium-based testing must be carefully weighed.<sup>
                  <xref ref-type="bibr" rid="bibr49-0885066611411408">49</xref>
               </sup>
            </p>
         </sec>
         <sec id="section10-0885066611411408">
            <title>Commonly Used Medications in the ICU</title>
            <p>Available information pertaining to commonly used ICU medications is generally limited to case reports and series. Summarized information can be found online through the Society of Critical Care Medicine Web site.<sup>
                  <xref ref-type="bibr" rid="bibr52-0885066611411408">52</xref>
               </sup> Whether a given medication crosses the placenta depends on physical properties such as molecular weight, lipid solubility, and degree of protein binding. Although the US Food and Drug Administration (FDA) pregnancy categories serve as a general guide with regard to safety, extrapolation of animal data is at best difficult, given the species-specific nature of teratogenicity. Furthermore, these categories exist in a vacuum—they cannot substitute for the nuanced decision making at the bedside, which factors in the indication for each drug as well as the potential risk to the mother and fetus if the disease is left uncontrolled or untreated. While most of the sedatives, anxiolytics, and narcotics commonly utilized in the ICU (described below) have potential side effects and are labeled as categories C and D, their use is generally safe and can be justified when medically indicated, such as in the gravid patient with profound respiratory failure needing advanced management of mechanical ventilation. As noted earlier, improving the status of the mother increases the likelihood of favorable fetal outcomes and, as such, the best policy is to carefully utilize these agents as in the nonpregnant patient, observing best practices and evidence-based guidelines.</p>
            <p>Benzodiazepines, a commonly utilized anxiolytic/hypnotic agent, are classified as pregnancy category D (<xref ref-type="table" rid="table3-0885066611411408">Table 3</xref>
). Benzodiazepines cross the placenta and may be associated with a small risk of congenital abnormalities and preterm birth when given early in pregnancy. When given around the time of delivery, benzodiazepines place the neonate at risk of respiratory depression and potential withdrawal syndromes.</p>
            <table-wrap id="table3-0885066611411408" position="float">
               <label>Table 3.</label>
               <caption>
                  <p>United States Food and Drug Administration Pharmaceutical Drug Safety Categories During Pregnancy.</p>
               </caption>
               <graphic alt-version="no" alternate-form-of="table3-0885066611411408" position="float" xlink:href="10.1177_0885066611411408-table3.tif" xlink:type="simple"/>
               <table>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1">Category</th>
                        <th colspan="1" rowspan="1">Risk</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">Category A</td>
                        <td colspan="1" rowspan="1">Adequate and well-controlled human studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters.</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Category B</td>
                        <td colspan="1" rowspan="1">Animal studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Category C</td>
                        <td colspan="1" rowspan="1">Animal studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant the use of the drug in pregnant women despite potential risks.</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Category D</td>
                        <td colspan="1" rowspan="1">There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant the use of the drug in pregnant women despite potential risks (eg, if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Category X</td>
                        <td colspan="1" rowspan="1">Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
            <p>Propofol appears to be safe when used short term, such as during cesarean deliveries. There are insufficient data regarding its safety when used for longer durations. As with benzodiazepines, newborns may suffer from respiratory suppression when given at the time of delivery, necessitating mechanical ventilator support.<sup>
                  <xref ref-type="bibr" rid="bibr53-0885066611411408">53</xref>
               </sup> It is classified as pregnancy category B, based on existing animal data.</p>
            <p>Only limited data exist regarding the safety and efficacy of dexmedetomidine during pregnancy. In vitro and animal data suggest an induction of myometrial contractions.<sup>
                  <xref ref-type="bibr" rid="bibr54-0885066611411408">54</xref>,<xref ref-type="bibr" rid="bibr55-0885066611411408">55</xref>
               </sup> Pending further data, dexmedetomidine should not be routinely used in pregnant patients in the ICU.</p>
            <p>No congenital defects have been reported in association with any of the narcotic agents used in the ICU. However, because data are limited, narcotics are classified as category D. Narcotics cross the placenta readily and can place newborns at risk of withdrawal and respiratory depression.</p>
            <p>Neuromuscular blocking agents cross the placenta as well but appear to be safe when given for short durations around the time of cesarean delivery or as a single dose.<sup>
                  <xref ref-type="bibr" rid="bibr56-0885066611411408">56</xref>
               </sup> Compared to adults, neonates tend to be more resistant to the neuromuscular blocking effects of these agents; therefore, when normal doses are given to the mother, there may be no discernable clinical effects on the fetus.<sup>
                  <xref ref-type="bibr" rid="bibr57-0885066611411408">57</xref>
               </sup> Regardless, when these agents are used near delivery, neonatologists must be informed and be prepared to provide the neonate with ventilator support. Medications used commonly to treat preeclampsia, such as phenytoin and magnesium sulfate, can interact with nondepolarizing neuromuscular blocking agents. Magnesium tends to prolong their duration of action.<sup>
                  <xref ref-type="bibr" rid="bibr58-0885066611411408">58</xref>
               </sup> Phenytoin can have different effects, depending on the chronicity of use. Chronic use can make patients resistant to paralytic actions.<sup>
                  <xref ref-type="bibr" rid="bibr59-0885066611411408">59</xref>,<xref ref-type="bibr" rid="bibr60-0885066611411408">60</xref>
               </sup> However, acute use can magnify and prolong the duration of neuromuscular blockade.<sup>
                  <xref ref-type="bibr" rid="bibr61-0885066611411408">61</xref>,<xref ref-type="bibr" rid="bibr62-0885066611411408">62</xref>
               </sup> Finally, it is important to note that plasma cholinesterase activity decreases during pregnancy and remains lower for a few months after delivery,<sup>
                  <xref ref-type="bibr" rid="bibr63-0885066611411408">63</xref>
               </sup> potentially prolonging the duration of paralysis when succinylcholine is used.</p>
         </sec>
      </sec>
      <sec id="section11-0885066611411408">
         <title>Commonly Encountered Conditions in the Critically Ill Obstetric Patient</title>
         <p>The following sections will briefly review commonly encountered conditions that lead to the admission of obstetric patients to the ICU—hypertensive disorders, postpartum hemorrhage, and sepsis. Space limitations prohibit discussion of many additional disorders associated with pregnancy such as amniotic fluid embolism, acute fatty liver of pregnancy, and peripartum cardiomyopathy. Excellent recent reviews are available for those interested in further exploration.<sup>
               <xref ref-type="bibr" rid="bibr64-0885066611411408">64</xref>,<xref ref-type="bibr" rid="bibr65-0885066611411408">65</xref>
            </sup>
         </p>
         <sec id="section12-0885066611411408">
            <title>Hypertensive Disease</title>
            <p>Hypertensive disorders complicate 2% to 8% of pregnancies and contribute greatly to maternal morbidity and mortality worldwide.<sup>
                  <xref ref-type="bibr" rid="bibr66-0885066611411408">66</xref>
               </sup> Preeclampsia is defined as new hypertension (systolic ≥140 mmHg or diastolic ≥90 mmHg) and proteinuria (&gt;300 mg in 24 hours) after the 20th week of gestation.<sup>
                  <xref ref-type="bibr" rid="bibr67-0885066611411408">67</xref>
               </sup> Although the exact cause of preeclampsia is unknown, impaired trophoblast invasion of the spiral arteries is thought to prevent normal perfusion of the placenta, leading to placental oxidative and endoplasmic reticulum stress.<sup>
                  <xref ref-type="bibr" rid="bibr68-0885066611411408">68</xref>
               </sup> Vascular dysfunction in the placenta promotes excessive endothelial activation and a procoagulant/proinflammatory milieu, contributing to systemic disease in the mother.</p>
            <p>Vascular dysfunction affects multiple organ systems—in particular, the central nervous system, liver, kidney, and blood. Clinical features of preeclampsia include edema, visual changes, headaches, and abdominal pain. The placenta and fetus are also vulnerable and pathological examination of the placenta reveals necrosis, thrombosis, and infarction. Preeclampsia can progress<sup>
                  <xref ref-type="bibr" rid="bibr69-0885066611411408">69</xref>
               </sup> to eclampsia with the development of seizures in 4% to 9%. Magnesium sulfate is effective for managing and preventing seizures and in fact may be superior to phenytoin in preventing recurrent seizures. Randomized-controlled trials support a regimen of 4 g intravenous loading dose over 15 minutes, followed by an infusion of 1 g/h.<sup>
                  <xref ref-type="bibr" rid="bibr70-0885066611411408">70</xref>,<xref ref-type="bibr" rid="bibr71-0885066611411408">71</xref>
               </sup> First or recurrent seizures can be treated with an additional 2 to 4 g intravenously. Clinical effect can be monitored by testing deep tendon reflexes. Serum magnesium levels can be monitored as well, with a goal range between 4 and 8 mg/dL.</p>
            <p>There is insufficient evidence to recommend using one agent over another to treat blood pressure.<sup>
                  <xref ref-type="bibr" rid="bibr72-0885066611411408">72</xref>
               </sup> However, on the basis of their known safety and efficacy, several agents are preferred, including nifedipine, nicardipine, labetalol, hydralazine, and methyldopa.<sup>
                  <xref ref-type="bibr" rid="bibr68-0885066611411408">68</xref>,<xref ref-type="bibr" rid="bibr73-0885066611411408">73</xref>,<xref ref-type="bibr" rid="bibr74-0885066611411408">74</xref>
               </sup> Typical dosing regimens are summarized in <xref ref-type="table" rid="table4-0885066611411408">Table 4</xref>
. Sodium nitroprusside, a vasodilatory agent that releases nitric oxide, is listed as pregnancy category C. Given its potential for cyanide toxicity and other side effects (such as increases in intracranial pressure, precipitous drops in blood pressure, and rebound hypertension), its use should be restricted for extreme cases of refractory hypertensive emergency after failure of all other agents.</p>
            <table-wrap id="table4-0885066611411408" position="float">
               <label>Table 4.</label>
               <caption>
                  <p>Agents Used and Typical Dosing Regimen for Management of Hypertension in Pregnancy.</p>
               </caption>
               <graphic alt-version="no" alternate-form-of="table4-0885066611411408" position="float" xlink:href="10.1177_0885066611411408-table4.tif" xlink:type="simple"/>
               <table>
                  <thead>
                     <tr>
                        <th colspan="1" rowspan="1">Drug</th>
                        <th colspan="1" rowspan="1">Dose</th>
                        <th colspan="1" rowspan="1">Onset of Action</th>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td colspan="3" rowspan="1">For severe hypertension—acute control</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Hydralazine</td>
                        <td colspan="1" rowspan="1">5-10 mg intravenously every 15-30 minutes to a maximum bolus dose of 20 mg. If no response to total dose of 30 mg, consider another agent.</td>
                        <td colspan="1" rowspan="1">10-20 minutes</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Labetalol</td>
                        <td colspan="1" rowspan="1">20 mg intravenously every 15-30 minutes to a maximum bolus dose of 80 mg (cumulative maximum 300 mg); 1-2 mg/minute as infusion</td>
                        <td colspan="1" rowspan="1">5 minutes</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Nicardipine</td>
                        <td colspan="1" rowspan="1">5 mg/h infusion; can uptitrate every 5 minutes by 2.5 mg/h to a maximum dose of 15 mg/h</td>
                        <td colspan="1" rowspan="1">10 minutes</td>
                     </tr>
                     <tr>
                        <td colspan="3" rowspan="1">For less severe hypertension</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Nifedipine (long acting)<sup>
                              <xref ref-type="table-fn" rid="table-fn4-0885066611411408">
a
</xref>
                           </sup>
                        </td>
                        <td colspan="1" rowspan="1">20-60 mg orally daily, maximum 120 mg per day</td>
                        <td colspan="1" rowspan="1">60 minutes</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Methyldopa</td>
                        <td colspan="1" rowspan="1">250-500 mg orally 2-4 times daily, maximum 2 g/d</td>
                        <td colspan="1" rowspan="1">3-6 hours (to peak action)</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Labetalol</td>
                        <td colspan="1" rowspan="1">100-400 mg orally 2-4 times daily, maximum 2400 mg/d</td>
                        <td colspan="1" rowspan="1">Variable, 20 minutes to 2 hours</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn id="table-fn4-0885066611411408">
                     <p>
                        <sup>a</sup> Immediate release nifedipine capsules are no longer available in many markets, due to safety concerns related to unpredictable decreases in blood pressure. It should not be used in women with known coronary artery disease, long-standing diabetes mellitus, or those above the age of 45 years, because of the risk of sudden cardiac death.</p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <p>Diazoxide can drop blood pressure precipitously and is best avoided. Nimodipine and magnesium sulfate are relatively ineffective agents for controlling blood pressure. Angiotensin-converting enzyme (ACE) inhibitors should be avoided in pregnancy. During the first trimester, ACE inhibitors increase the risk of cardiovascular and central nervous system malformation.<sup>
                  <xref ref-type="bibr" rid="bibr75-0885066611411408">75</xref>
               </sup> When used during later trimesters, ACE inhibitors may cause fetal renal dysgenesis as well as other developmental abnormalities. Similarly, angiotensin II receptor antagonists should be avoided during pregnancy because they have a mechanism of action similar to that of ACE inhibitors.</p>
            <p>Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome complicates preeclampsia in 10% to 20%. Although HELLP is felt to occur within the spectrum of preeclampsia, it can occur without hypertension or proteinuria in approximately 15%. Hemolysis, elevated liver enzymes, and low platelet (HELLP) places the woman at risk of developing placental abruption, disseminated intravascular coagulation, acute kidney injury, and hepatic failure. Plasma exchange has been used in the management of patients with severe HELLP. Although there are no formal randomized prospective studies (and such a study is likely not forthcoming), patients with severe organ failure refractory to standard treatment are considered candidates.<sup>
                  <xref ref-type="bibr" rid="bibr76-0885066611411408">76</xref>
               </sup> For women at or near term, expedited delivery of the fetus is considered standard of care. Although administration of corticosteroids has been shown to increase the platelet count,<sup>
                  <xref ref-type="bibr" rid="bibr77-0885066611411408">77</xref>
               </sup> more recent evidence suggests steroids do not improve maternal or perinatal outcome.<sup>
                  <xref ref-type="bibr" rid="bibr78-0885066611411408">78</xref>,<xref ref-type="bibr" rid="bibr79-0885066611411408">79</xref>
               </sup> Recent detailed reviews of preeclampsia and HELLP can be found elsewhere for the reader interested in more in-depth discussion.<sup>
                  <xref ref-type="bibr" rid="bibr68-0885066611411408">68</xref>,<xref ref-type="bibr" rid="bibr80-0885066611411408">80</xref>,<xref ref-type="bibr" rid="bibr81-0885066611411408">81</xref>
               </sup>
            </p>
            <p>Pulmonary edema and associated respiratory failure is another complication encountered in preeclampsia, and typically occurs postpartum. Decreased oncotic pressure, increased hydrostatic pressure, fluid overload, and hypoalbuminemia set the stage for development of pulmonary edema. Fluid intake should be restricted, supportive supplemental oxygen therapy provided if necessary, and diuretic treatment initiated with close monitoring of intake and output.</p>
         </sec>
         <sec id="section13-0885066611411408">
            <title>Postpartum Hemorrhage</title>
            <p>Worldwide, obstetric hemorrhage is the leading cause of maternal morbidity and mortality. Bleeding can occur before or after delivery. Antepartum hemorrhage occurs in approximately 5% to 6% of pregnancies and can cause serious complications when associated with abnormal placentation (such as placenta previa or abruption). Postpartum hemorrhage remains one of the top indications for ICU admission in many series.<sup>
                  <xref ref-type="bibr" rid="bibr3-0885066611411408">3</xref>
                  <xref ref-type="bibr" rid="bibr4-0885066611411408"/>
                  <xref ref-type="bibr" rid="bibr5-0885066611411408"/>–<xref ref-type="bibr" rid="bibr6-0885066611411408">6</xref>
               </sup> Postpartum hemorrhage affects 5% of deliveries and is technically defined as a blood loss of more than 500 mL within the first 24 hours after delivery of the newborn after vaginal delivery, or more than 1000 mL after cesarean delivery. The inciting events that lead to excessive bleeding are (1) uterine atony, which accounts for 50% to 60% of cases, (2) retained placenta, seen in 20% to 30%, and (3) cervical or vaginal laceration, which is a complication seen in 10%. Uterine atony is typically painless, and on examination the uterus is soft and oversized. The degree of blood loss may initially be inconspicuous, as the blood can hide in the uterus. After compression of the uterine fundus—blood may be seen externally. Initial steps for management include bladder emptying, administration of oxytocin, and uterine massage. When retained placenta is suspected, manual exploration of the uterus and removal of placenta must promptly occur. Finally, with regard to cervical and/or vaginal lacerations, a careful examination and wound repair usually suffices.</p>
            <p>If the above measures fail, and brisk bleeding persists, recommendations are to administer prostaglandin (intravenous prostaglandin E2/sulprostone or intramuscular 15-methyl prostaglandin F<sub>2α</sub>/carboprost) and to consider uterine balloon tamponade adapting a Sengstaken-Blakemore catheter as an adjunctive measure within 30 minutes.<sup>
                  <xref ref-type="bibr" rid="bibr82-0885066611411408">82</xref>,<xref ref-type="bibr" rid="bibr83-0885066611411408">83</xref>
               </sup> If after an additional ½ hour adequate hemostasis has not been achieved, surgical artery ligation or embolization attempts by an experienced interventional radiology team must be considered.<sup>
                  <xref ref-type="bibr" rid="bibr84-0885066611411408">84</xref>,<xref ref-type="bibr" rid="bibr85-0885066611411408">85</xref>
               </sup> Hysterectomy is reserved as a last resort. Thankfully, the need for this drastic measure is becoming increasingly rare with improved supportive care.<sup>
                  <xref ref-type="bibr" rid="bibr86-0885066611411408">86</xref>
               </sup>
            </p>
            <p>General ICU care employed for any patient with massive hemorrhage or shock applies to the perigravid patient. Adequate intravenous access must be secured immediately (multiple large bore peripherals or a 9F large bore central venous introducer catheter). Volume expansion with crystalloids as well as blood products should follow, and vasopressor therapy should be initiated, if necessary, to maintain an adequate perfusion pressure. Use of a rapid transfusion device should be considered, and a warming device should be applied (if indicated) to correct hypothermia-induced coagulopathy. Attention to such details is important to optimize therapy. For example, hypothermia has been shown to cause abnormal platelet adhesion and aggregation and reduce thrombin generation. Some have estimated that for each 1°C lowering of body temperature, there can be a 10% reduction in coagulation factor activity.<sup>
                  <xref ref-type="bibr" rid="bibr87-0885066611411408">87</xref>
               </sup> The effect of hypothermia on coagulation is often underestimated because laboratory assays are routinely performed at 37°C. Although there is debate regarding the exact threshold at which additional blood products should be given, it is now widely accepted that dilution and consumption of clotting factors and platelets occur after multiple packed red blood cells are transfused.<sup>
                  <xref ref-type="bibr" rid="bibr88-0885066611411408">88</xref>
               </sup> Some massive transfusion protocols advocate for early plasma and platelet transfusions so that the replaced blood more closely mimics the proportions seen in whole blood.<sup>
                  <xref ref-type="bibr" rid="bibr83-0885066611411408">83</xref>
               </sup> Patients must be closely monitored as they are at risk of developing respiratory failure due to transfusion-related acute lung injury (TRALI) and simple volume overload (particularly given the relatively low oncotic pressures seen during pregnancy, as described in an earlier section).</p>
         </sec>
      </sec>
      <sec id="section14-0885066611411408">
         <title>Infections</title>
         <sec id="section15-0885066611411408">
            <title>General Management Principles</title>
            <p>Fever is a common presenting symptom that triggers an evaluation in pregnant women. A number of infectious and noninfectious causes should be considered (<xref ref-type="table" rid="table5-0885066611411408">Table 5</xref>
).<sup>
                  <xref ref-type="bibr" rid="bibr89-0885066611411408">89</xref>
               </sup> Sepsis complicates approximately 1 in 8000 pregnancies. Severe manifestations are rare. In one study of 74 patients admitted to the ICU, 59% had manifestations of systemic inflammatory response syndrome (SIRS), 25% had sepsis, and only 3% had septic shock.<sup>
                  <xref ref-type="bibr" rid="bibr90-0885066611411408">90</xref>
               </sup> Infections originating in the genitourinary tract are important to consider because pregnancy-related changes in urinary tract anatomy (such as pressure on the bladder from the gravid uterus causing relative obstruction and stasis, and smooth muscle relaxation which increase the size of the ureter) increase the risk of pyelonephritis. Pyelonephritis can complicate up to 1.4% of deliveries.<sup>
                  <xref ref-type="bibr" rid="bibr91-0885066611411408">91</xref>
               </sup> Escherichia coli is the most frequently recovered microbe. Chorioamnionitis, postpartum endometritis, as well as wound infections from an episiotomy site are other common pregnancy-specific infections to consider. Although intra-amniotic fluid infections can be seen in up to 10% of deliveries,<sup>
                  <xref ref-type="bibr" rid="bibr92-0885066611411408">92</xref>
               </sup> sepsis occurs in only 1.3%.<sup>
                  <xref ref-type="bibr" rid="bibr93-0885066611411408">93</xref>
               </sup> Prolonged rupture of membranes, retained products of conception, and instrumentation of the genitourinary tract are associated with a higher risk of sepsis. Amniotic fluid infections are classically polymicrobial, which should be a consideration when selecting empiric antibiotics. Postpartum endometritis is typically seen following cesarean section, and as in chorioamnionitis, is often polymicrobial in nature. Broad-spectrum antibiotics are necessary and must have appropriate coverage of anaerobic organisms. β-lactams and clindamycin are considered safe to use during pregnancy (category B) and there is a general consensus regarding safety and clinical experience with regard to aminoglycosides (category D).<sup>
                  <xref ref-type="bibr" rid="bibr94-0885066611411408">94</xref>
               </sup>
            </p>
            <table-wrap id="table5-0885066611411408" position="float">
               <label>Table 5.</label>
               <caption>
                  <p>Causes of Fever in a Pregnant Patient.</p>
               </caption>
               <graphic alt-version="no" alternate-form-of="table5-0885066611411408" position="float" xlink:href="10.1177_0885066611411408-table5.tif" xlink:type="simple"/>
               <table>
                  <tbody>
                     <tr>
                        <td colspan="1" rowspan="1">Obstetric</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Intra-amniotic infection</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Chorioamnionitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Premature rupture of membranes</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Amnionitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Postpartum endometritis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Septic abortion</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Episiotomy infection</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Cellulitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Necrotizing fasciitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Myonecrosis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Septic pelvic thrombophlebitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Mastitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1">Nonobstetric</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Urinary tract infection</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Uncomplicated urinary tract infection</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Pyelonephritis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Pneumonia</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Community-acquired pneumonia</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Bacterial</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Viral (varicella, influenza, SARS)</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Fungal</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Hospital-acquired pneumonia</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Aspiration pneumonia</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Intra-abdominal infections</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Appendicitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Cholecystitis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Viral hepatitis (A, B, C, D, E)</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Human immunodeficiency virus</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Malaria</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Lyme disease</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Disseminated herpes infections</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Listeriosis</td>
                     </tr>
                     <tr>
                        <td colspan="1" rowspan="1"> Sexually transmitted diseases</td>
                     </tr>
                  </tbody>
               </table>
               <table-wrap-foot>
                  <fn id="table-fn5-0885066611411408">
                     <p>Abbreviation: SARS, severe acute respiratory syndrome.</p>
                  </fn>
                  <fn id="table-fn6-0885066611411408">
                     <p>
                        <sup>a</sup> Adapted with permission from Soubra et al. Crit Care Med 2005; 33(suppl): S248-255.<sup>
                           <xref ref-type="bibr" rid="bibr89-0885066611411408">89</xref>
                        </sup>
                     </p>
                  </fn>
               </table-wrap-foot>
            </table-wrap>
            <p>General management principles (including early goal-directed therapy) for sepsis apply to the perigravid patient and include appropriate fluid resuscitation and hemodynamic support, nutritional support, source control, as well as early and appropriate antibiotics.<sup>
                  <xref ref-type="bibr" rid="bibr25-0885066611411408">25</xref>
               </sup> Activated protein C is not well studied in pregnancy, but case reports do exist.<sup>
                  <xref ref-type="bibr" rid="bibr95-0885066611411408">95</xref>,<xref ref-type="bibr" rid="bibr96-0885066611411408">96</xref>
               </sup>
            </p>
         </sec>
         <sec id="section16-0885066611411408">
            <title>Pneumonia</title>
            <p>Prevalence and hospitalization rates for pneumonia are similar between pregnant and nonpregnant controls.<sup>
                  <xref ref-type="bibr" rid="bibr97-0885066611411408">97</xref>
               </sup> However, respiratory failure due to pneumonia was the third leading indication for intubation during pregnancy and accounted for 12% of intubated obstetric patients in one series.<sup>
                  <xref ref-type="bibr" rid="bibr98-0885066611411408">98</xref>
               </sup> Severe pneumonia and respiratory failure in turn lead to more preterm labor and higher fetal mortality related to prematurity. Therefore, fetal status should be monitored by an appropriate method (taking into consideration the gestational age), in conjunction with maternal–fetal medicine specialists.</p>
            <p>Despite pregnancy-related changes in immunity, community-acquired pneumonia with the usual bacterial pathogens are still the most common cause of pneumonia. In up to two thirds of cases, the etiological microbe is not recovered.<sup>
                  <xref ref-type="bibr" rid="bibr97-0885066611411408">97</xref>
               </sup> The existence of comorbid illnesses plays an important role. In one study, patients with asthma and anemia appeared to be at increased risk for pneumonia during pregnancy, with an odds ratio of 5.3 and 9.9, respectively.<sup>
                  <xref ref-type="bibr" rid="bibr99-0885066611411408">99</xref>
               </sup> When triaging a pregnant woman, available pneumonia severity scoring tools appear to correctly identify patients that may have a complicated course and may help guide decisions whether patients can be safely discharged or require admission to the hospital or the ICU.<sup>
                  <xref ref-type="bibr" rid="bibr100-0885066611411408">100</xref>
               </sup>
            </p>
            <p>Immunological changes that occur in pregnancy, compounded by maternal physiologic changes (such as increased oxygen consumption and changes in lung function) increase the risk of severe viral infections. Viral pneumonias are often complicated by secondary bacterial infections, frank respiratory failure, and ARDS. During pregnancy, there is a shift from cell-mediated to humoral immunity, which occurs as an adaptive response to accept the genetically different fetus.<sup>
                  <xref ref-type="bibr" rid="bibr101-0885066611411408">101</xref>,<xref ref-type="bibr" rid="bibr102-0885066611411408">102</xref>
               </sup> Decreases in T-helper cells, natural killer cell activity, as well as lymphocyte proliferation have been documented during pregnancy. Because cell-mediated immunity facilitates recognition and destruction of intracellular pathogens, it follows that pregnant women are particularly vulnerable to developing severe viral infections.</p>
            <p>Varicella and influenza are the most common pathogens associated with viral pneumonia. While the risk of pulmonary involvement from varicella is comparable to nonpregnant adults (5.5%-16.5%),<sup>
                  <xref ref-type="bibr" rid="bibr103-0885066611411408">103</xref>
               </sup> approximately 50% need mechanical ventilator support once pneumonitis develops. Nonimmune women who get exposed to the virus should be given varicella zoster immunoglobulin within 96 hours. The use of adjunctive corticosteroids for life-threatening varicella pneumonia is controversial and not standard practice, but small studies suggest a potential benefit in selected subgroups.<sup>
                  <xref ref-type="bibr" rid="bibr104-0885066611411408">104</xref>,<xref ref-type="bibr" rid="bibr105-0885066611411408">105</xref>
               </sup>
            </p>
         </sec>
         <sec id="section17-0885066611411408">
            <title>Influenza</title>
            <p>The recent H1N1 influenza pandemic raised awareness regarding the potential for catastrophic illness during pregnancy. During the 2009 flu season in New York City, pregnant women were 7 times more likely to be hospitalized with H1N1 influenza compared to nonpregnant reproductive age women, and 4 times more likely to develop severe infection defined as a need for the ICU or ultimate death. This latter finding suggested that pregnant women experienced more severe disease and were not just hospitalized more frequently.<sup>
                  <xref ref-type="bibr" rid="bibr106-0885066611411408">106</xref>
               </sup>
            </p>
            <p>A large database accumulated by the Centers for Disease Control and Prevention (CDC) showed that between April and August 2009, 65% of 788 pregnant women with proven H1N1 infection were hospitalized. Of those hospitalized, nearly a quarter developed severe disease necessitating ICU level care and a fifth required intubation. Approximately half of pregnant women with H1N1 had an underlying comorbid condition with obesity, asthma, and diabetes (both pregnancy related and nonpregnancy related) as the leading diagnoses. Those who were hospitalized, admitted to the ICU, or died were more likely to have a concurrent comorbid condition. Influenza infection had a significant impact on the fetus as well, as a third of pregnancies that ended with a live birth were born prematurely. Pregnant women accounted for 5% of the influenza-related deaths reported to the CDC in the same period.<sup>
                  <xref ref-type="bibr" rid="bibr107-0885066611411408">107</xref>
               </sup> The study also highlighted the importance of early recognition and treatment, as pregnant women who were given oseltamivir within 48 hours did well, with a 0.5% maternal mortality. In comparison, those who received treatment between days 3 and 4 after symptom onset had a 10-fold increase in mortality, while those delayed beyond 4 days were 54 times more likely to die. Among survivors, earlier treatment was associated with less severe disease even when it was given outside of the FDA-approved 48-hour window.<sup>
                  <xref ref-type="bibr" rid="bibr108-0885066611411408">108</xref>
               </sup> With regard to safety of oseltamivir, the drug is extensively metabolized by the placenta in ex-vivo models, leading to undetectable levels in the fetus even at doses above the FDA recommended dose.<sup>
                  <xref ref-type="bibr" rid="bibr109-0885066611411408">109</xref>
               </sup> Although large clinical studies are lacking, it is generally considered safe to use during pregnancy—and given the high stakes to the mother and the fetus, its use can be justified.<sup>
                  <xref ref-type="bibr" rid="bibr110-0885066611411408">110</xref>
               </sup>
            </p>
         </sec>
      </sec>
      <sec id="section18-0885066611411408">
         <title>Ethical Concerns When Caring for the Pregnant Patient</title>
         <p>Assessment of capacity becomes important if the critically ill pregnant woman is under sedatives, too sick, or too delirious to participate in decision making. When the patient is unable to make decisions, the principles of substituted judgment is applied and an appropriate proxy identified. It is worth noting that more recently, there has been some interest in a different decision-making framework coined, “substituted interest.”<sup>
               <xref ref-type="bibr" rid="bibr111-0885066611411408">111</xref>
            </sup> This model promotes surrogate decision making in the context of the patient’s known values, wishes, and interests and strives to promote shared decision making with the clinician, who makes specific recommendations tailored to the individual patient.</p>
         <p>Rarely, situations arise in which the pregnant women’s autonomy and the fetus' best interest conflict. This becomes particularly troubling when the pregnancy has reached viability.<sup>
               <xref ref-type="bibr" rid="bibr112-0885066611411408">112</xref>
            </sup> When fetal health can be improved indirectly through treatment of the mother, or when there is a direct intervention that can be performed on the fetus, the fetus can be considered a potential patient. However, conferring the status of “patient” to the fetus is difficult, as it immediately brings to the forefront the existing debate over the moral and legal status of the fetus. To date, no legal right has been granted to the fetus. The moral right of the fetus (and in particular, the right to life) is a matter of contentious ethical debate. A competent pregnant woman’s refusal of a recommended intervention that in turn may jeopardize the health of the fetus poses a problem for the treating physician. The American College of Obstetrics and Gynecology (ACOG) recognizes 3 options: (1) respecting the mother’s autonomy, regardless of the consequences, (2) counseling the mother and, if no agreement can be reached, referring her to a colleague willing to oblige to the woman’s request or be willing to repeat counseling efforts, and (3) requesting a court order in order to override the woman’s autonomy. The ACOG discourages the use of the last option and favors dialogue. Although it is appropriate to encourage the patient to consider the fetus's welfare when making treatment choices, it is ultimately the woman’s prerogative to refuse recommended therapies and interventions, assuming she is competent and fully informed.</p>
         <p>The professional’s obligation to save the mother’s life always overrides the physician’s duty to the fetus. Thankfully, in most circumstances, the well-being of the mother and the fetus converge—treatments that improve maternal status help the fetus as well. However, if maternal death is considered imminent (or the mother is brain dead), the welfare of the fetus becomes central. Regardless, no action should be against the woman’s expressed wishes. Fetal viability, health status of the fetus, and the views of the family and partner/husband must be concurrently considered in such situations.<sup>
               <xref ref-type="bibr" rid="bibr113-0885066611411408">113</xref>
            </sup>
         </p>
         <p>Although strong data are lacking, fetal survival is generally considered unlikely if more than 15 to 20 minutes had elapsed since loss of maternal spontaneous circulation. In 1986, recommendations were made suggesting that physicians should perform a perimortem cesarean delivery within 4 minutes of cardiac arrest. This was justified based on the assumption that cardiopulmonary resuscitation (CPR) efforts would not be as effective in the third trimester because of aortocaval compression which limits cardiac output, and that fetal and maternal outcomes may be optimized immediately by delivery.<sup>
               <xref ref-type="bibr" rid="bibr114-0885066611411408">114</xref>,<xref ref-type="bibr" rid="bibr115-0885066611411408">115</xref>
            </sup> In 2005, review of the literature identified 38 cases of perimortem delivery, in which 34 infants survived.<sup>
               <xref ref-type="bibr" rid="bibr116-0885066611411408">116</xref>
            </sup> Of 20 patients with potentially resuscitatable causes of cardiac arrest, 13 were successfully resuscitated and left the hospital in good condition. Among 18 patients who had detailed hemodynamic data, 12 experienced return of maternal pulse and blood pressure promptly after cesarean delivery, suggesting that this was beneficial. Cardiopulmonary resuscitation should continue uninterrupted during and following delivery.</p>
      </sec>
      <sec id="section19-0885066611411408">
         <title>Summary</title>
         <p>Fortunately, critical illness rarely complicates pregnancy. Hypertensive disorders, postpartum hemorrhage, and sepsis are leading diagnoses when ICU admission becomes necessary. Successful management of the peripartum patient requires an understanding of the normal physiologic changes that accompany pregnancy. Collaboration with specialists in maternal–fetal medicine is paramount. The consequences and safety of common diagnostic tests and procedures as well as medications must be considered. The recent H1N1 pandemic influenza has raised awareness about the challenges that accompany the care of this vulnerable population.</p>
      </sec>
   </body>
   <back>
      <fn-group>
         <fn fn-type="conflict" id="fn1-0885066611411408">
            <label>Declaration of Conflicting Interests</label>
            <p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
         </fn>
         <fn fn-type="financial-disclosure" id="fn2-0885066611411408">
            <label>Funding</label>
            <p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
         </fn>
      </fn-group>
      <ref-list>
         <title>References</title>
         <ref id="bibr1-0885066611411408">
            <label>1</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mahutte</surname>
                     <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Murphy-Kaulbeck</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Le</surname>
                     <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Solomon</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Benjamin</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Boyd</surname>
                     <given-names>ME</given-names>
                  </name>
               </person-group>. <article-title>Obstetric admissions to the intensive care unit</article-title>. <source>Obstet Gynecol</source>. <year>1999</year>;<volume>94</volume>(<issue>2</issue>):<fpage>263</fpage>–<lpage>266</lpage>.</citation>
         </ref>
         <ref id="bibr2-0885066611411408">
            <label>2</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Madan</surname>
                     <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Puri</surname>
                     <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Jain</surname>
                     <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grotegut</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nelson</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dandolu</surname>
                     <given-names>V</given-names>
                  </name>
               </person-group>. <article-title>Characteristics of obstetric intensive care unit admissions in New Jersey</article-title>. <source>J Matern Fetal Neonatal Med</source>. <year>2009</year>;<volume>22</volume>(<issue>9</issue>):<fpage>785</fpage>–<lpage>790</lpage>.</citation>
         </ref>
         <ref id="bibr3-0885066611411408">
            <label>3</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hazelgrove</surname>
                     <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Price</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pappachan</surname>
                     <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Smith</surname>
                     <given-names>GB</given-names>
                  </name>
               </person-group>. <article-title>Multicenter study of obstetric admissions to 14 intensive care units in southern England</article-title>. <source>Crit Care Med</source>. <year>2001</year>;<volume>29</volume>(<issue>4</issue>):<fpage>770</fpage>–<lpage>775</lpage>.</citation>
         </ref>
         <ref id="bibr4-0885066611411408">
            <label>4</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Keizer</surname>
                     <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Zwart</surname>
                     <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Meerman</surname>
                     <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Harinck</surname>
                     <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Feuth</surname>
                     <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>van Roosmalen</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Obstetric intensive care admissions: a 12-year review in a tertiary care centre</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2006</year>;<volume>128</volume>(<issue>1-2</issue>):<fpage>152</fpage>–<lpage>156</lpage>.</citation>
         </ref>
         <ref id="bibr5-0885066611411408">
            <label>5</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kilpatrick</surname>
                     <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Matthay</surname>
                     <given-names>MA</given-names>
                  </name>
               </person-group>. <article-title>Obstetric patients requiring critical care. A five-year review</article-title>. <source>Chest</source>. <year>1992</year>;<volume>101</volume>(<issue>5</issue>):<fpage>1407</fpage>–<lpage>1412</lpage>.</citation>
         </ref>
         <ref id="bibr6-0885066611411408">
            <label>6</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Vasquez</surname>
                     <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Estenssoro</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Canales</surname>
                     <given-names>HS</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Clinical characteristics and outcomes of obstetric patients requiring ICU admission</article-title>. <source>Chest</source>. <year>Mar 2007</year>;<volume>131</volume>(<issue>3</issue>):<fpage>718</fpage>–<lpage>724</lpage>.</citation>
         </ref>
         <ref id="bibr7-0885066611411408">
            <label>7</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Baskett</surname>
                     <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sternadel</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Maternal intensive care and near-miss mortality in obstetrics</article-title>. <source>Br J Obstet Gynaecol</source>. <year>1998</year>;<volume>105</volume>(<issue>9</issue>):<fpage>981</fpage>–<lpage>984</lpage>.</citation>
         </ref>
         <ref id="bibr8-0885066611411408">
            <label>8</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Heinonen</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tyrvainen</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Saarikoski</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ruokonen</surname>
                     <given-names>E</given-names>
                  </name>
               </person-group>. <article-title>Need for maternal critical care in obstetrics: a population-based analysis</article-title>. <source>Int J Obstet Anesth</source>. <year>2002</year>;<volume>11</volume>(<issue>4</issue>):<fpage>260</fpage>–<lpage>264</lpage>.</citation>
         </ref>
         <ref id="bibr9-0885066611411408">
            <label>9</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Lapinsky</surname>
                     <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kruczynski</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Seaward</surname>
                     <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Farine</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grossman</surname>
                     <given-names>RF</given-names>
                  </name>
               </person-group>. <article-title>Critical care management of the obstetric patient</article-title>. <source>Can J Anaesth</source>. <year>1997</year>;<volume>44</volume>(<issue>3</issue>):<fpage>325</fpage>–<lpage>329</lpage>.</citation>
         </ref>
         <ref id="bibr10-0885066611411408">
            <label>10</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Brown</surname>
                     <given-names>CM</given-names>
                  </name>
               </person-group>. <article-title>Severe influenza A virus (H1N1) infection in pregnancy</article-title>. <source>Obstet Gynecol</source>. <year>2010</year>;<volume>115</volume>(<issue>2 pt 2</issue>):<fpage>412</fpage>–<lpage>414</lpage>.</citation>
         </ref>
         <ref id="bibr11-0885066611411408">
            <label>11</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Davies</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Jones</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bailey</surname>
                     <given-names>M</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>(<issue>17</issue>):<fpage>1888</fpage>–<lpage>1895</lpage>.</citation>
         </ref>
         <ref id="bibr12-0885066611411408">
            <label>12</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Loverro</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pansini</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Greco</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Vimercati</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Parisi</surname>
                     <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Selvaggi</surname>
                     <given-names>L</given-names>
                  </name>
               </person-group>. <article-title>Indications and outcome for intensive care unit admission during puerperium</article-title>. <source>Arch Gynecol Obstet</source>. <year>2001</year>;<volume>265</volume>(<issue>4</issue>):<fpage>195</fpage>–<lpage>198</lpage>.</citation>
         </ref>
         <ref id="bibr13-0885066611411408">
            <label>13</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mabie</surname>
                     <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sibai</surname>
                     <given-names>BM</given-names>
                  </name>
               </person-group>. <article-title>Treatment in an obstetric intensive care unit</article-title>. <source>Am J Obstet Gynecol</source>. <year>1990</year>;<volume>162</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>4</lpage>.</citation>
         </ref>
         <ref id="bibr14-0885066611411408">
            <label>14</label>
            <citation citation-type="web" xlink:type="simple">
               <ext-link ext-link-type="uri" xlink:href="http://www.census.gov/population/www.socdemo/fertility.html#hist" xlink:type="simple">http://www.census.gov/population/www.socdemo/fertility.html#hist</ext-link>, <comment>Supplemental Table 1, accessed July 27, 2010</comment>.
</citation>
         </ref>
         <ref id="bibr15-0885066611411408">
            <label>15</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Davies</surname>
                     <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Maxwell</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>McLeod</surname>
                     <given-names>L</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Obesity in pregnancy. No. 239, February 2010</article-title>. <source>Int J Gynaecol Obstet</source>. <year>2010</year>;<volume>110</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>173</lpage>.</citation>
         </ref>
         <ref id="bibr16-0885066611411408">
            <label>16</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Galtier-Dereure</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Boegner</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bringer</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Obesity and pregnancy: complications and cost</article-title>. <source>Am J Clin Nutr</source>. <year>2000</year>;<volume>71</volume>(<issue>5 suppl</issue>):<fpage>1242S</fpage>–<lpage>1248S</lpage>.</citation>
         </ref>
         <ref id="bibr17-0885066611411408">
            <label>17</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dietz</surname>
                     <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>England</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Morrow</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Callaghan</surname>
                     <given-names>WM</given-names>
                  </name>
               </person-group>. <article-title>Trends in pre-pregnancy obesity in nine states, 1993-2003</article-title>. <source>Obesity (Silver Spring)</source>. <year>2007</year>;<volume>15</volume>(<issue>4</issue>):<fpage>986</fpage>–<lpage>993</lpage>.</citation>
         </ref>
         <ref id="bibr18-0885066611411408">
            <label>18</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hunter</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>The management of “psychogenic” orofacial pain</article-title>. <source>BMJ</source>. <year>1992</year>;<volume>304</volume>(<issue>6823</issue>):<fpage>329</fpage>–<lpage>330</lpage>.</citation>
         </ref>
         <ref id="bibr19-0885066611411408">
            <label>19</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Crapo</surname>
                     <given-names>RO</given-names>
                  </name>
               </person-group>. <article-title>Normal cardiopulmonary physiology during pregnancy</article-title>. <source>Clin Obstet Gynecol</source>. <year>1996</year>;<volume>39</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>16</lpage>.</citation>
         </ref>
         <ref id="bibr20-0885066611411408">
            <label>20</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Pritchard</surname>
                     <given-names>JA</given-names>
                  </name>
               </person-group>. <article-title>Changes in the blood volume during pregnancy and delivery</article-title>. <source>Anesthesiology</source>. <year>1965</year>;<volume>26</volume>:<fpage>393</fpage>–<lpage>399</lpage>.</citation>
         </ref>
         <ref id="bibr21-0885066611411408">
            <label>21</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Oian</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Maltau</surname>
                     <given-names>JM</given-names>
                  </name>
               </person-group>. <article-title>Transcapillary forces in normal pregnant women</article-title>. <source>Acta Med Scand Suppl</source>. <year>1985</year>;<volume>693</volume>:<fpage>19</fpage>–<lpage>22</lpage>.</citation>
         </ref>
         <ref id="bibr22-0885066611411408">
            <label>22</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Capeless</surname>
                     <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Clapp</surname>
                     <given-names>JF</given-names>
                  </name>
               </person-group>. <article-title>When do cardiovascular parameters return to their preconception values?</article-title> 
               <source>Am J Obstet Gynecol</source>. <year>1991</year>;<volume>165</volume>(<issue>4 pt 1</issue>):<fpage>883</fpage>–<lpage>886</lpage>.</citation>
         </ref>
         <ref id="bibr23-0885066611411408">
            <label>23</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Shnider</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>de Lorimier</surname>
                     <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Holl</surname>
                     <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chapler</surname>
                     <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Morishima</surname>
                     <given-names>HO</given-names>
                  </name>
               </person-group>. <article-title>Vasopressors in obstetrics. I. Correction of fetal acidosis with ephedrine during spinal hypotension</article-title>. <source>Am J Obstet Gynecol</source>. <year>1968</year>;<volume>102</volume>(<issue>7</issue>):<fpage>911</fpage>–<lpage>919</lpage>.</citation>
         </ref>
         <ref id="bibr24-0885066611411408">
            <label>24</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Lee</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ngan Kee</surname>
                     <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gin</surname>
                     <given-names>T</given-names>
                  </name>
               </person-group>. <article-title>A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery</article-title>. <source>Anesth Analg</source>. <year>2002</year>;<volume>94</volume>(<issue>4</issue>):<fpage>920</fpage>–<lpage>926</lpage>.</citation>
         </ref>
         <ref id="bibr25-0885066611411408">
            <label>25</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Guinn</surname>
                     <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Abel</surname>
                     <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tomlinson</surname>
                     <given-names>MW</given-names>
                  </name>
               </person-group>. <article-title>Early goal directed therapy for sepsis during pregnancy</article-title>. <source>Obstet Gynecol Clin North Am</source>. <year>2007</year>;<volume>34</volume>(<issue>3</issue>):<fpage>459</fpage>–<lpage>479</lpage>.</citation>
         </ref>
         <ref id="bibr26-0885066611411408">
            <label>26</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cheun</surname>
                     <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Choi</surname>
                     <given-names>KT</given-names>
                  </name>
               </person-group>. <article-title>Arterial oxygen desaturation rate following obstructive apnea in parturients</article-title>. <source>J Korean Med Sci</source>. <year>1992</year>;<volume>7</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>10</lpage>.</citation>
         </ref>
         <ref id="bibr27-0885066611411408">
            <label>27</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>King</surname>
                     <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Adams</surname>
                     <given-names>AP</given-names>
                  </name>
               </person-group>. <article-title>Failed tracheal intubation</article-title>. <source>Br J Anaesth</source>. <year>1990</year>;<volume>65</volume>(<issue>3</issue>):<fpage>400</fpage>–<lpage>414</lpage>.</citation>
         </ref>
         <ref id="bibr28-0885066611411408">
            <label>28</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Izci</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Riha</surname>
                     <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Martin</surname>
                     <given-names>SE</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>The upper airway in pregnancy and pre-eclampsia</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2003</year>;<volume>167</volume>(<issue>2</issue>):<fpage>137</fpage>–<lpage>140</lpage>.</citation>
         </ref>
         <ref id="bibr29-0885066611411408">
            <label>29</label>
            <citation citation-type="journal" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome</collab>. <article-title>The acute respiratory distress syndrome network</article-title>. <source>N Engl J Med</source>. <year>2000</year>;<volume>342</volume>(<issue>18</issue>):<fpage>1301</fpage>–<lpage>1308</lpage>.</citation>
         </ref>
         <ref id="bibr30-0885066611411408">
            <label>30</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cole</surname>
                     <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Taylor</surname>
                     <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>McCullough</surname>
                     <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Shoff</surname>
                     <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Derdak</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Acute respiratory distress syndrome in pregnancy</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>10 suppl</issue>):<fpage>S269</fpage>–<lpage>S278</lpage>.</citation>
         </ref>
         <ref id="bibr31-0885066611411408">
            <label>31</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Levinson</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Shnider</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>DeLorimier</surname>
                     <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Steffenson</surname>
                     <given-names>JL</given-names>
                  </name>
               </person-group>. <article-title>Effects of maternal hyperventilation on uterine blood flow and fetal oxygenation and acid-base status</article-title>. <source>Anesthesiology</source>. <year>1974</year>;<volume>40</volume>(<issue>4</issue>):<fpage>340</fpage>–<lpage>347</lpage>.</citation>
         </ref>
         <ref id="bibr32-0885066611411408">
            <label>32</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Ivankovic</surname>
                     <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Elam</surname>
                     <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Huffman</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Effect of maternal hypercarbia on the newborn infant</article-title>. <source>Am J Obstet Gynecol</source>. <year>1970</year>;<volume>107</volume>(<issue>6</issue>):<fpage>939</fpage>–<lpage>946</lpage>.</citation>
         </ref>
         <ref id="bibr33-0885066611411408">
            <label>33</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Varughese</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Patole</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Shama</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Whitehall</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly</article-title>. <source>Pediatr Pulmonol</source>. <year>2002</year>;<volume>33</volume>(<issue>1</issue>):<fpage>56</fpage>–<lpage>64</lpage>.</citation>
         </ref>
         <ref id="bibr34-0885066611411408">
            <label>34</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Fraser</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Jensen</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wolfe</surname>
                     <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hahn</surname>
                     <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Davies</surname>
                     <given-names>GA</given-names>
                  </name>
               </person-group>. <article-title>Fetal heart rate response to maternal hypocapnia and hypercapnia in late gestation</article-title>. <source>J Obstet Gynaecol Can</source>. <year>2008</year>;<volume>30</volume>(<issue>4</issue>):<fpage>312</fpage>–<lpage>316</lpage>.</citation>
         </ref>
         <ref id="bibr35-0885066611411408">
            <label>35</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Ritchie</surname>
                     <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lakhani</surname>
                     <given-names>K</given-names>
                  </name>
               </person-group>. <article-title>Fetal breathing movements in response to maternal inhalation of 5% carbon dioxide</article-title>. <source>Am J Obstet Gynecol</source>. <year>1980</year>;<volume>136</volume>(<issue>3</issue>):<fpage>386</fpage>–<lpage>388</lpage>.</citation>
         </ref>
         <ref id="bibr36-0885066611411408">
            <label>36</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Catanzarite</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Willms</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wong</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Landers</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cousins</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Schrimmer</surname>
                     <given-names>D</given-names>
                  </name>
               </person-group>. <article-title>Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes</article-title>. <source>Obstet Gynecol</source>. <year>2001</year>;<volume>97</volume>(<issue>5 pt 1</issue>):<fpage>760</fpage>–<lpage>764</lpage>.</citation>
         </ref>
         <ref id="bibr37-0885066611411408">
            <label>37</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hirani</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Marik</surname>
                     <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Plante</surname>
                     <given-names>LA</given-names>
                  </name>
               </person-group>. <article-title>Airway pressure-release ventilation in pregnant patients with acute respiratory distress syndrome: a novel strategy</article-title>. <source>Respir Care</source>. <year>2009</year>;<volume>54</volume>(<issue>10</issue>):<fpage>1405</fpage>–<lpage>1408</lpage>.</citation>
         </ref>
         <ref id="bibr38-0885066611411408">
            <label>38</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kenn</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Weber-Carstens</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Weizsaecker</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bercker</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Prone positioning for ARDS following blunt chest trauma in late pregnancy</article-title>. <source>Int J Obstet Anesth</source>. <year>2009</year>;<volume>18</volume>(<issue>3</issue>):<fpage>268</fpage>–<lpage>271</lpage>.</citation>
         </ref>
         <ref id="bibr39-0885066611411408">
            <label>39</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Briel</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Meade</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mercat</surname>
                     <given-names>A</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>9</issue>):<fpage>865</fpage>–<lpage>873</lpage>.</citation>
         </ref>
         <ref id="bibr40-0885066611411408">
            <label>40</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Tomlinson</surname>
                     <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Caruthers</surname>
                     <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Whitty</surname>
                     <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gonik</surname>
                     <given-names>B</given-names>
                  </name>
               </person-group>. <article-title>Does delivery improve maternal condition in the respiratory-compromised gravida?</article-title> 
               <source>Obstet Gynecol</source>. <year>1998</year>;<volume>91</volume>(<issue>1</issue>):<fpage>108</fpage>–<lpage>111</lpage>.</citation>
         </ref>
         <ref id="bibr41-0885066611411408">
            <label>41</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Collop</surname>
                     <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sahn</surname>
                     <given-names>SA</given-names>
                  </name>
               </person-group>. <article-title>Critical illness in pregnancy. An analysis of 20 patients admitted to a medical intensive care unit</article-title>. <source>Chest</source>. <year>1993</year>;<volume>103</volume>(<issue>5</issue>):<fpage>1548</fpage>–<lpage>1552</lpage>.</citation>
         </ref>
         <ref id="bibr42-0885066611411408">
            <label>42</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>De Santis</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cesari</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nobili</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Straface</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cavaliere</surname>
                     <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Caruso</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>. <article-title>Radiation effects on development</article-title>. <source>Birth Defects Res C Embryo Today</source>. <year>2007</year>;<volume>81</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>182</lpage>.</citation>
         </ref>
         <ref id="bibr43-0885066611411408">
            <label>43</label>
            <citation citation-type="web" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">Centers for Disease Control and Prevention</collab>. <article-title>Radiation and pregnancy: a fact sheet for clinicians</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.bt.cdc.gov/radiation/prenatalphysician.asp" xlink:type="simple">http://www.bt.cdc.gov/radiation/prenatalphysician.asp</ext-link>. <comment>
                  <italic>Accessed September 20, 2010</italic>
               </comment>.
</citation>
         </ref>
         <ref id="bibr44-0885066611411408">
            <label>44</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Matthews</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Short communication: imaging pulmonary embolism in pregnancy: what is the most appropriate imaging protocol?</article-title> 
               <source>Br J Radiol</source>. <year>2006</year>;<volume>79</volume>(<issue>941</issue>):<fpage>441</fpage>–<lpage>444</lpage>.</citation>
         </ref>
         <ref id="bibr45-0885066611411408">
            <label>45</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Smith-Bindman</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lipson</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Marcus</surname>
                     <given-names>R</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer</article-title>. <source>Arch Intern Med</source>. <year>2009</year>;<volume>169</volume>(<issue>22</issue>):<fpage>2078</fpage>–<lpage>2086</lpage>.</citation>
         </ref>
         <ref id="bibr46-0885066611411408">
            <label>46</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Berrington de Gonzalez</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mahesh</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>KP</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Projected cancer risks from computed tomographic scans performed in the United States in 2007</article-title>. <source>Arch Intern Med</source>. <year>2009</year>;<volume>169</volume>(<issue>22</issue>):<fpage>2071</fpage>–<lpage>2077</lpage>.</citation>
         </ref>
         <ref id="bibr47-0885066611411408">
            <label>47</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Winer-Muram</surname>
                     <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Boone</surname>
                     <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Brown</surname>
                     <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Jennings</surname>
                     <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mabie</surname>
                     <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lombardo</surname>
                     <given-names>GT</given-names>
                  </name>
               </person-group>. <article-title>Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT</article-title>. <source>Radiology</source>. <year>2002</year>;<volume>224</volume>(<issue>2</issue>):<fpage>487</fpage>–<lpage>492</lpage>.</citation>
         </ref>
         <ref id="bibr48-0885066611411408">
            <label>48</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Chan</surname>
                     <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ray</surname>
                     <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Murray</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Coady</surname>
                     <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Coates</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ginsberg</surname>
                     <given-names>JS</given-names>
                  </name>
               </person-group>. <article-title>Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes</article-title>. <source>Arch Intern Med</source>. <year>2002</year>;<volume>162</volume>(<issue>10</issue>):<fpage>1170</fpage>–<lpage>1175</lpage>.</citation>
         </ref>
         <ref id="bibr49-0885066611411408">
            <label>49</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Chen</surname>
                     <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Coakley</surname>
                     <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kaimal</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Laros</surname>
                     <given-names>RK</given-names>
                     <suffix>Jr</suffix>
                  </name>
               </person-group>. <article-title>Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation</article-title>. <source>Obstet Gynecol</source>. <year>2008</year>;<volume>112</volume>(<issue>2 pt 1</issue>):<fpage>333</fpage>–<lpage>340</lpage>.</citation>
         </ref>
         <ref id="bibr50-0885066611411408">
            <label>50</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Bona</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Zaffaroni</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Defilippi</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gallina</surname>
                     <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mostert</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Effects of iopamidol on neonatal thyroid function</article-title>. <source>Eur J Radiol</source>. <year>1992</year>;<volume>14</volume>(<issue>1</issue>):<fpage>22</fpage>–<lpage>25</lpage>.</citation>
         </ref>
         <ref id="bibr51-0885066611411408">
            <label>51</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Bourjeily</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chalhoub</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Phornphutkul</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Alleyne</surname>
                     <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Woodfield</surname>
                     <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chen</surname>
                     <given-names>KK</given-names>
                  </name>
               </person-group>. <article-title>Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero</article-title>. <source>Radiology</source>. <year>2010</year>;<volume>256</volume>(<issue>3</issue>):<fpage>744</fpage>–<lpage>750</lpage>.</citation>
         </ref>
         <ref id="bibr52-0885066611411408">
            <label>52</label>
            <citation citation-type="web" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">Society of Critical Care Medicine</collab>. <ext-link ext-link-type="uri" xlink:href="http://www.sccm.org/Publications/Critical_Connections/Archives/August2010/Pages/PregnancyintheICU.aspx" xlink:type="simple">http://www.sccm.org/Publications/Critical_Connections/Archives/August2010/Pages/PregnancyintheICU.aspx</ext-link>. <comment>Accessed September 19, 2010.Hockman, RH and Kelsey J. Pregnancy in the ICU: Drug Implications</comment>.
</citation>
         </ref>
         <ref id="bibr53-0885066611411408">
            <label>53</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Bacon</surname>
                     <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Razis</surname>
                     <given-names>PA</given-names>
                  </name>
               </person-group>. <article-title>The effect of propofol sedation in pregnancy on neonatal condition</article-title>. <source>Anaesthesia</source>. <year>1994</year>;<volume>49</volume>(<issue>12</issue>):<fpage>1058</fpage>–<lpage>1060</lpage>.</citation>
         </ref>
         <ref id="bibr54-0885066611411408">
            <label>54</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Karaman</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Evren</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Firat</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cankayali</surname>
                     <given-names>I</given-names>
                  </name>
               </person-group>. <article-title>The effects of dexmedetomidine on spontaneous contractions of isolated gravid rat myometrium</article-title>. <source>Adv Ther</source>. <year>2006</year>;<volume>23</volume>(<issue>2</issue>):<fpage>238</fpage>–<lpage>243</lpage>.</citation>
         </ref>
         <ref id="bibr55-0885066611411408">
            <label>55</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Sia</surname>
                     <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kwek</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Yeo</surname>
                     <given-names>GS</given-names>
                  </name>
               </person-group>. <article-title>The in vitro effects of clonidine and dexmedetomidine on human myometrium</article-title>. <source>Int J Obstet Anesth</source>. <year>2005</year>;<volume>14</volume>(<issue>2</issue>):<fpage>104</fpage>–<lpage>107</lpage>.</citation>
         </ref>
         <ref id="bibr56-0885066611411408">
            <label>56</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Guay</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grenier</surname>
                     <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Varin</surname>
                     <given-names>F</given-names>
                  </name>
               </person-group>. <article-title>Clinical pharmacokinetics of neuromuscular relaxants in pregnancy</article-title>. <source>Clin Pharmacokinet</source>. <year>1998</year>;<volume>34</volume>(<issue>6</issue>):<fpage>483</fpage>.</citation>
         </ref>
         <ref id="bibr57-0885066611411408">
            <label>57</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Booij</surname>
                     <given-names>LH</given-names>
                  </name>
               </person-group>. <article-title>Neuromuscular transmission and its pharmacological blockade. Part 4: use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit</article-title>. <source>Pharm World Sci</source>. <year>1997</year>;<volume>19</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>52</lpage>.</citation>
         </ref>
         <ref id="bibr58-0885066611411408">
            <label>58</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Yoshida</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Itoh</surname>
                     <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nagaya</surname>
                     <given-names>K</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Prolonged relaxant effects of vecuronium in patients with deliberate hypermagnesemia: time for caution in cesarean section</article-title>. <source>J Anesth</source>. <year>2006</year>;<volume>20</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>35</lpage>.</citation>
         </ref>
         <ref id="bibr59-0885066611411408">
            <label>59</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Richard</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Girard</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Girard</surname>
                     <given-names>DC</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients</article-title>. <source>Anesth Analg</source>. <year>2005</year>;<volume>100</volume>(<issue>2</issue>):<fpage>538</fpage>–<lpage>544</lpage>.</citation>
         </ref>
         <ref id="bibr60-0885066611411408">
            <label>60</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hernandez-Palazon</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tortosa</surname>
                     <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Martinez-Lage</surname>
                     <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Perez-Ayala</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy</article-title>. <source>J Neurosurg Anesthesiol</source>. <year>2001</year>;<volume>13</volume>(<issue>2</issue>):<fpage>79</fpage>–<lpage>82</lpage>.</citation>
         </ref>
         <ref id="bibr61-0885066611411408">
            <label>61</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Baumgardner</surname>
                     <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bagshaw</surname>
                     <given-names>R</given-names>
                  </name>
               </person-group>. <article-title>Acute versus chronic phenytoin therapy and neuromuscular blockade</article-title>. <source>Anaesthesia</source>. <year>1990</year>;<volume>45</volume>(<issue>6</issue>):<fpage>493</fpage>–<lpage>494</lpage>.</citation>
         </ref>
         <ref id="bibr62-0885066611411408">
            <label>62</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Gray</surname>
                     <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Slater</surname>
                     <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pollard</surname>
                     <given-names>BJ</given-names>
                  </name>
               </person-group>. <article-title>The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade</article-title>. <source>Anaesthesia</source>. <year>1989</year>;<volume>44</volume>(<issue>5</issue>):<fpage>379</fpage>–<lpage>381</lpage>.</citation>
         </ref>
         <ref id="bibr63-0885066611411408">
            <label>63</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Leighton</surname>
                     <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cheek</surname>
                     <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gross</surname>
                     <given-names>JB</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Succinylcholine pharmacodynamics in peripartum patients</article-title>. <source>Anesthesiology</source>. <year>1986</year>;<volume>64</volume>(<issue>2</issue>):<fpage>202</fpage>–<lpage>205</lpage>.</citation>
         </ref>
         <ref id="bibr64-0885066611411408">
            <label>64</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Bourjeily</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Miller</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Obstetric disorders in the ICU</article-title>. <source>Clin Chest Med</source>. <year>2009</year>;<volume>30</volume>(<issue>1</issue>):<fpage>89</fpage>–<lpage>102</lpage>.</citation>
         </ref>
         <ref id="bibr65-0885066611411408">
            <label>65</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Martin</surname>
                     <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Foley</surname>
                     <given-names>MR</given-names>
                  </name>
               </person-group>. <article-title>Intensive care in obstetrics: an evidence-based review</article-title>. <source>Am J Obstet Gynecol</source>. <year>2006</year>;<volume>195</volume>(<issue>3</issue>):<fpage>673</fpage>–<lpage>689</lpage>.</citation>
         </ref>
         <ref id="bibr66-0885066611411408">
            <label>66</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Khan</surname>
                     <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wojdyla</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Say</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gulmezoglu</surname>
                     <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Van Look</surname>
                     <given-names>PF</given-names>
                  </name>
               </person-group>. <article-title>WHO analysis of causes of maternal death: a systematic review</article-title>. <source>Lancet</source>. <year>2006</year>;<volume>367</volume>(<issue>9516</issue>):<fpage>1066</fpage>–<lpage>1074</lpage>.</citation>
         </ref>
         <ref id="bibr67-0885066611411408">
            <label>67</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Milne</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Redman</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Walker</surname>
                     <given-names>J</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community</article-title>. <source>BMJ</source>. <year>2005</year>;<volume>330</volume>(<issue>7491</issue>):<fpage>576</fpage>–<lpage>580</lpage>.</citation>
         </ref>
         <ref id="bibr68-0885066611411408">
            <label>68</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Steegers</surname>
                     <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>von Dadelszen</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Duvekot</surname>
                     <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pijnenborg</surname>
                     <given-names>R</given-names>
                  </name>
               </person-group>. <article-title>Pre-eclampsia</article-title>. <source>Lancet</source>. <year>2010</year>;<volume>376</volume>(<issue>9741</issue>):<fpage>631</fpage>–<lpage>644</lpage>.</citation>
         </ref>
         <ref id="bibr69-0885066611411408">
            <label>69</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Henry</surname>
                     <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Biedermann</surname>
                     <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Campbell</surname>
                     <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Guntupalli</surname>
                     <given-names>JS</given-names>
                  </name>
               </person-group>. <article-title>Spectrum of hypertensive emergencies in pregnancy</article-title>. <source>Crit Care Clin</source>. <year>2004</year>;<volume>20</volume>(<issue>4</issue>):<fpage>697</fpage>–<lpage>712</lpage>.</citation>
         </ref>
         <ref id="bibr70-0885066611411408">
            <label>70</label>
            <citation citation-type="journal" xlink:type="simple">
               <article-title>The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial</article-title>. <source>Lancet</source>. <year>1995</year>;<volume>345</volume>(<issue>8963</issue>):<fpage>1455</fpage>–<lpage>1463</lpage>.</citation>
         </ref>
         <ref id="bibr71-0885066611411408">
            <label>71</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Altman</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Carroli</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Duley</surname>
                     <given-names>L</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial</article-title>. <source>Lancet</source>. <year>2002</year>;<volume>359</volume>(<issue>9321</issue>):<fpage>1877</fpage>–<lpage>1890</lpage>.</citation>
         </ref>
         <ref id="bibr72-0885066611411408">
            <label>72</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Duley</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hederson-Smart</surname>
                     <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Meher</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Drugs for treatment of very high blood pressure during pregnancy</article-title>. <source>Cochrane Database Syst Rev.</source> 
               <year>2006 Jul 19</year>;<comment>3: CD001449</comment>.
</citation>
         </ref>
         <ref id="bibr73-0885066611411408">
            <label>73</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>McCoy</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baldwin</surname>
                     <given-names>K</given-names>
                  </name>
               </person-group>. <article-title>Pharmacotherapeutic options for the treatment of preeclampsia</article-title>. <source>Am J Health Syst Pharm</source>. <year>2009</year>;<volume>66</volume>(<issue>4</issue>):<fpage>337</fpage>–<lpage>344</lpage>.</citation>
         </ref>
         <ref id="bibr74-0885066611411408">
            <label>74</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Vidaeff</surname>
                     <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Carroll</surname>
                     <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ramin</surname>
                     <given-names>SM</given-names>
                  </name>
               </person-group>. <article-title>Acute hypertensive emergencies in pregnancy</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>10 suppl</issue>):<fpage>S307</fpage>–<lpage>S312</lpage>.</citation>
         </ref>
         <ref id="bibr75-0885066611411408">
            <label>75</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cooper</surname>
                     <given-names>WO</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hernandez-Diaz</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Arbogast</surname>
                     <given-names>PG</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Major congenital malformations after first-trimester exposure to ACE inhibitors</article-title>. <source>N Engl J Med</source>. <year>2006</year>;<volume>354</volume>(<issue>23</issue>):<fpage>2443</fpage>–<lpage>2451</lpage>.</citation>
         </ref>
         <ref id="bibr76-0885066611411408">
            <label>76</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Eser</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Guven</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Unal</surname>
                     <given-names>A</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>The role of plasma exchange in HELLP syndrome</article-title>. <source>Clin Appl Thromb Hemost</source>. <year>2005</year>;<volume>11</volume>(<issue>2</issue>):<fpage>211</fpage>–<lpage>217</lpage>.</citation>
         </ref>
         <ref id="bibr77-0885066611411408">
            <label>77</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Martin</surname>
                     <given-names>JN</given-names>
                     <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                     <surname>Thigpen</surname>
                     <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Rose</surname>
                     <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cushman</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Moore</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>May</surname>
                     <given-names>WL</given-names>
                  </name>
               </person-group>. <article-title>Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome</article-title>. <source>Am J Obstet Gynecol</source>. <year>2003</year>;<volume>189</volume>(<issue>3</issue>):<fpage>830</fpage>–<lpage>834</lpage>.</citation>
         </ref>
         <ref id="bibr78-0885066611411408">
            <label>78</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Katz</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>de Amorim</surname>
                     <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Figueiroa</surname>
                     <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pinto e Silva</surname>
                     <given-names>JL</given-names>
                  </name>
               </person-group>. <article-title>Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>198</volume>(<issue>3</issue>):<fpage>283,e1</fpage>–<lpage>e8</lpage>.</citation>
         </ref>
         <ref id="bibr79-0885066611411408">
            <label>79</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Woudstra</surname>
                     <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chandra</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hofmeyr</surname>
                     <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dowswell</surname>
                     <given-names>T</given-names>
                  </name>
               </person-group>. <article-title>Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy</article-title>. <source>Cochrane Database Syst Rev.</source> 
               <year>2010 Sept 8</year>; <comment>9: CD008148</comment>.
</citation>
         </ref>
         <ref id="bibr80-0885066611411408">
            <label>80</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kirkpatrick</surname>
                     <given-names>CA</given-names>
                  </name>
               </person-group>. <article-title>The HELLP syndrome</article-title>. <source>Acta Clin Belg</source>. <year>2010</year>;<volume>65</volume>(<issue>2</issue>):<fpage>91</fpage>–<lpage>97</lpage>.</citation>
         </ref>
         <ref id="bibr81-0885066611411408">
            <label>81</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Marik</surname>
                     <given-names>PE</given-names>
                  </name>
               </person-group>. <article-title>Hypertensive disorders of pregnancy</article-title>. <source>Postgrad Med</source>. <year>2009</year>;<volume>121</volume>(<issue>2</issue>):<fpage>69</fpage>–<lpage>76</lpage>.</citation>
         </ref>
         <ref id="bibr82-0885066611411408">
            <label>82</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Doumouchtsis</surname>
                     <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Papageorghiou</surname>
                     <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Arulkumaran</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails</article-title>. <source>Obstet Gynecol Surv</source>. <year>2007</year>;<volume>62</volume>(<issue>8</issue>):<fpage>540</fpage>–<lpage>547</lpage>.</citation>
         </ref>
         <ref id="bibr83-0885066611411408">
            <label>83</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mercier</surname>
                     <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Van de Velde</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Major obstetric hemorrhage</article-title>. <source>Anesthesiol Clin</source>. <year>2008</year>;<volume>26</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>66</lpage>.</citation>
         </ref>
         <ref id="bibr84-0885066611411408">
            <label>84</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hong</surname>
                     <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tseng</surname>
                     <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lee</surname>
                     <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wang</surname>
                     <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chang</surname>
                     <given-names>CY</given-names>
                  </name>
               </person-group>. <article-title>Uterine artery embolization: an effective treatment for intractable obstetric haemorrhage</article-title>. <source>Clin Radiol</source>. <year>2004</year>;<volume>59</volume>(<issue>1</issue>):<fpage>96</fpage>–<lpage>101</lpage>.</citation>
         </ref>
         <ref id="bibr85-0885066611411408">
            <label>85</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Soncini</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pelicelli</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Larini</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Marcato</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Monaco</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grignaffini</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>. <article-title>Uterine artery embolization in the treatment and prevention of postpartum hemorrhage</article-title>. <source>Int J Gynaecol Obstet</source>. <year>2007</year>;<volume>96</volume>(<issue>3</issue>):<fpage>181</fpage>–<lpage>185</lpage>.</citation>
         </ref>
         <ref id="bibr86-0885066611411408">
            <label>86</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Habek</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Becarevic</surname>
                     <given-names>R</given-names>
                  </name>
               </person-group>. <article-title>Emergency peripartum hysterectomy in a tertiary obstetric center: 8-year evaluation</article-title>. <source>Fetal Diagn Ther</source>. <year>2007</year>;<volume>22</volume>(<issue>2</issue>):<fpage>139</fpage>–<lpage>142</lpage>.</citation>
         </ref>
         <ref id="bibr87-0885066611411408">
            <label>87</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Watts</surname>
                     <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Trask</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Soeken</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Perdue</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dols</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kaufmann</surname>
                     <given-names>C</given-names>
                  </name>
               </person-group>. <article-title>Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity</article-title>. <source>J Trauma</source>. <year>1998</year>;<volume>44</volume>(<issue>5</issue>):<fpage>846</fpage>–<lpage>854</lpage>.</citation>
         </ref>
         <ref id="bibr88-0885066611411408">
            <label>88</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Johansson</surname>
                     <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ostrowski</surname>
                     <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Secher</surname>
                     <given-names>NH</given-names>
                  </name>
               </person-group>. <article-title>Management of major blood loss: An update</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>2010</year>;<volume>54</volume>(<issue>9</issue>):<fpage>1039</fpage>–<lpage>1049</lpage>.</citation>
         </ref>
         <ref id="bibr89-0885066611411408">
            <label>89</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Soubra</surname>
                     <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Guntupalli</surname>
                     <given-names>KK</given-names>
                  </name>
               </person-group>. <article-title>Critical illness in pregnancy: an overview</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>10 suppl</issue>):<fpage>S248</fpage>–<lpage>S255</lpage>.</citation>
         </ref>
         <ref id="bibr90-0885066611411408">
            <label>90</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Afessa</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Green</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Delke</surname>
                     <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Koch</surname>
                     <given-names>K</given-names>
                  </name>
               </person-group>. <article-title>Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU</article-title>. <source>Chest</source>. <year>2001</year>;<volume>120</volume>(<issue>4</issue>):<fpage>1271</fpage>–<lpage>1277</lpage>.</citation>
         </ref>
         <ref id="bibr91-0885066611411408">
            <label>91</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hill</surname>
                     <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sheffield</surname>
                     <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>McIntire</surname>
                     <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wendel</surname>
                     <given-names>GD</given-names>
                     <suffix>Jr</suffix>
                  </name>
               </person-group>. <article-title>Acute pyelonephritis in pregnancy</article-title>. <source>Obstet Gynecol</source>. <year>2005</year>;<volume>105</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>23</lpage>.</citation>
         </ref>
         <ref id="bibr92-0885066611411408">
            <label>92</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Soper</surname>
                     <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mayhall</surname>
                     <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dalton</surname>
                     <given-names>HP</given-names>
                  </name>
               </person-group>. <article-title>Risk factors for intraamniotic infection: a prospective epidemiologic study</article-title>. <source>Am J Obstet Gynecol</source>. <year>1989</year>;<volume>161</volume>(<issue>3</issue>):<fpage>562</fpage>–<lpage>566</lpage>.<comment>discussion 566-568.</comment>
            </citation>
         </ref>
         <ref id="bibr93-0885066611411408">
            <label>93</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Rouse</surname>
                     <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Landon</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Leveno</surname>
                     <given-names>KJ</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>191</volume>(<issue>1</issue>):<fpage>211</fpage>–<lpage>216</lpage>.</citation>
         </ref>
         <ref id="bibr94-0885066611411408">
            <label>94</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hopkins</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Smaill</surname>
                     <given-names>F</given-names>
                  </name>
               </person-group>. <article-title>Antibiotic regimens for management of intraamniotic infection</article-title>. <source>Cochrane Database Syst Rev.</source> 
               <year>2002</year>; <comment>3: CD003254</comment>.
</citation>
         </ref>
         <ref id="bibr95-0885066611411408">
            <label>95</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Medve</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Csitari</surname>
                     <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Molnar</surname>
                     <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Laszlo</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>. <article-title>Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report</article-title>. <source>Am J Obstet Gynecol</source>. <year>2005</year>;<volume>193</volume>(<issue>3 pt 1</issue>):<fpage>864</fpage>–<lpage>865</lpage>.</citation>
         </ref>
         <ref id="bibr96-0885066611411408">
            <label>96</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mikaszewska-Sokolewicz</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mayzner-Zawadzka</surname>
                     <given-names>E</given-names>
                  </name>
               </person-group>. <article-title>Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome</article-title>. <source>Med Sci Monit</source>. <year>2005</year>;<volume>11</volume>(<issue>6</issue>):<fpage>CS27</fpage>–<lpage>CS32</lpage>.</citation>
         </ref>
         <ref id="bibr97-0885066611411408">
            <label>97</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Goodnight</surname>
                     <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Soper</surname>
                     <given-names>DE</given-names>
                  </name>
               </person-group>. <article-title>Pneumonia in pregnancy</article-title>. <source>Crit Care Med</source>. <year>2005</year>;<volume>33</volume>(<issue>10 suppl</issue>):<fpage>S390</fpage>–<lpage>S397</lpage>.</citation>
         </ref>
         <ref id="bibr98-0885066611411408">
            <label>98</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Jenkins</surname>
                     <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Troiano</surname>
                     <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Graves</surname>
                     <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baird</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Boehm</surname>
                     <given-names>FH</given-names>
                  </name>
               </person-group>. <article-title>Mechanical ventilation in an obstetric population: characteristics and delivery rates</article-title>. <source>Am J Obstet Gynecol</source>. <year>2003</year>;<volume>188</volume>(<issue>2</issue>):<fpage>549</fpage>–<lpage>552</lpage>.</citation>
         </ref>
         <ref id="bibr99-0885066611411408">
            <label>99</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Munn</surname>
                     <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Groome</surname>
                     <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Atterbury</surname>
                     <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baker</surname>
                     <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hoff</surname>
                     <given-names>C</given-names>
                  </name>
               </person-group>. <article-title>Pneumonia as a complication of pregnancy</article-title>. <source>J Matern Fetal Med</source>. <year>1999</year>;<volume>8</volume>(<issue>4</issue>):<fpage>151</fpage>–<lpage>154</lpage>.</citation>
         </ref>
         <ref id="bibr100-0885066611411408">
            <label>100</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Yost</surname>
                     <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bloom</surname>
                     <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Richey</surname>
                     <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ramin</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cunningham</surname>
                     <given-names>FG</given-names>
                  </name>
               </person-group>. <article-title>An appraisal of treatment guidelines for antepartum community-acquired pneumonia</article-title>. <source>Am J Obstet Gynecol</source>. <year>2000</year>;<volume>183</volume>(<issue>1</issue>):<fpage>131</fpage>–<lpage>135</lpage>.</citation>
         </ref>
         <ref id="bibr101-0885066611411408">
            <label>101</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Jamieson</surname>
                     <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Theiler</surname>
                     <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Rasmussen</surname>
                     <given-names>SA</given-names>
                  </name>
               </person-group>. <article-title>Emerging infections and pregnancy</article-title>. <source>Emerg Infect Dis</source>. <year>2006</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1638</fpage>–<lpage>1643</lpage>.</citation>
         </ref>
         <ref id="bibr102-0885066611411408">
            <label>102</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Szekeres-Bartho</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Immunological relationship between the mother and the fetus</article-title>. <source>Int Rev Immunol</source>. <year>2002</year>;<volume>21</volume>(<issue>6</issue>):<fpage>471</fpage>–<lpage>495</lpage>.</citation>
         </ref>
         <ref id="bibr103-0885066611411408">
            <label>103</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Baren</surname>
                     <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Henneman</surname>
                     <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lewis</surname>
                     <given-names>RJ</given-names>
                  </name>
               </person-group>. <article-title>Primary varicella in adults: pneumonia, pregnancy, and hospital admission</article-title>. <source>Ann Emerg Med</source>. <year>1996</year>;<volume>28</volume>(<issue>2</issue>):<fpage>165</fpage>–<lpage>169</lpage>.</citation>
         </ref>
         <ref id="bibr104-0885066611411408">
            <label>104</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mer</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Richards</surname>
                     <given-names>GA</given-names>
                  </name>
               </person-group>. <article-title>Corticosteroids in life-threatening varicella pneumonia</article-title>. <source>Chest</source>. <year>1998</year>;<volume>114</volume>(<issue>2</issue>):<fpage>426</fpage>–<lpage>431</lpage>.</citation>
         </ref>
         <ref id="bibr105-0885066611411408">
            <label>105</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cheng</surname>
                     <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tang</surname>
                     <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wu</surname>
                     <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chu</surname>
                     <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Yuen</surname>
                     <given-names>KY</given-names>
                  </name>
               </person-group>. <article-title>Medical treatment of viral pneumonia including SARS in immunocompetent adult</article-title>. <source>J Infect</source>. <year>2004</year>;<volume>49</volume>(<issue>4</issue>):<fpage>262</fpage>–<lpage>273</lpage>.</citation>
         </ref>
         <ref id="bibr106-0885066611411408">
            <label>106</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Creanga</surname>
                     <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Graitcer</surname>
                     <given-names>SB</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women</article-title>. <source>Obstet Gynecol</source>. <year>2010</year>;<volume>115</volume>(<issue>4</issue>):<fpage>717</fpage>–<lpage>726</lpage>.</citation>
         </ref>
         <ref id="bibr107-0885066611411408">
            <label>107</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Siston</surname>
                     <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Rasmussen</surname>
                     <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Honein</surname>
                     <given-names>MA</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>15</issue>):<fpage>1517</fpage>–<lpage>1525</lpage>.</citation>
         </ref>
         <ref id="bibr108-0885066611411408">
            <label>108</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Fiore</surname>
                     <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Shay</surname>
                     <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Broder</surname>
                     <given-names>K</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008</article-title>. <source>MMWR Recomm Rep</source>. <year>2008</year>;<volume>57</volume>(<issue>RR-7</issue>):<fpage>1</fpage>–<lpage>60</lpage>.</citation>
         </ref>
         <ref id="bibr109-0885066611411408">
            <label>109</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Worley</surname>
                     <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Roberts</surname>
                     <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bawdon</surname>
                     <given-names>RE</given-names>
                  </name>
               </person-group>. <article-title>The metabolism and transplacental transfer of oseltamivir in the ex vivo human model</article-title>. <source>Infect Dis Obstet Gynecol</source>. <year>2008</year>; <comment>Article ID 927574</comment>.
</citation>
         </ref>
         <ref id="bibr110-0885066611411408">
            <label>110</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Tanaka</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nakajima</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Murashima</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Garcia-Bournissen</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Koren</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ito</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women</article-title>. <source>CMAJ</source>. <year>2009</year>;<volume>181</volume>(<issue>1-2</issue>):<fpage>55</fpage>–<lpage>58</lpage>.</citation>
         </ref>
         <ref id="bibr111-0885066611411408">
            <label>111</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Sulmasy</surname>
                     <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Snyder</surname>
                     <given-names>L</given-names>
                  </name>
               </person-group>. <article-title>Substituted interests and best judgments: an integrated model of surrogate decision making</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>304</volume>(<issue>17</issue>):<fpage>1946</fpage>–<lpage>1947</lpage>.</citation>
         </ref>
         <ref id="bibr112-0885066611411408">
            <label>112</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>van Bogaert</surname>
                     <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dhai</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>. <article-title>Ethical challenges of treating the critically ill pregnant patient</article-title>. <source>Best Pract Res Clin Obstet Gynaecol</source>. <year>2008</year>;<volume>22</volume>(<issue>5</issue>):<fpage>983</fpage>–<lpage>996</lpage>.</citation>
         </ref>
         <ref id="bibr113-0885066611411408">
            <label>113</label>
            <citation citation-type="web" xlink:type="simple">
               <ext-link ext-link-type="uri" xlink:href="http:www.figo.org/files/figo-corp/Ethical%20Issues%20-%20English.pdf" xlink:type="simple">http:www.figo.org/files/figo-corp/Ethical%20Issues%20-%20English.pdf</ext-link>. <comment>Accessed Septemnber 24, 2010</comment>.
</citation>
         </ref>
         <ref id="bibr114-0885066611411408">
            <label>114</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Katz</surname>
                     <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dotters</surname>
                     <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Droegemueller</surname>
                     <given-names>W</given-names>
                  </name>
               </person-group>. <article-title>Perimortem cesarean delivery</article-title>. <source>Obstet Gynecol</source>. <year>1986</year>;<volume>68</volume>(<issue>4</issue>):<fpage>571</fpage>–<lpage>576</lpage>.</citation>
         </ref>
         <ref id="bibr115-0885066611411408">
            <label>115</label>
            <citation citation-type="journal" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">ACOG educational bulletin</collab>. <article-title>Obstetric aspects of trauma management. Number 251, September 1998 (replaces Number 151, January 1991, and Number 161, November 1991). American College of Obstetricians and Gynecologists</article-title>. <source>Int J Gynaecol Obstet</source>. <year>1999</year>;<volume>64</volume>(<issue>1</issue>):<fpage>87</fpage>–<lpage>94</lpage>.</citation>
         </ref>
         <ref id="bibr116-0885066611411408">
            <label>116</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Katz</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Balderston</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>DeFreest</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Perimortem cesarean delivery: were our assumptions correct?</article-title> 
               <source>Am J Obstet Gynecol</source>. <year>2005</year>;<volume>192</volume>(<issue>6</issue>):<fpage>1916</fpage>–<lpage>1920</lpage>; <comment>discussion 1920-1911.</comment>.
</citation>
         </ref>
         <ref id="bibr117-0885066611411408">
            <label>117</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Williams</surname>
                     <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Fletcher</surname>
                     <given-names>S</given-names>
                  </name>
               </person-group>. <article-title>Health effects of prenatal radiation exposure</article-title>. <source>Am Fam Physician</source>. <year>2010</year>;<volume>82</volume>(<issue>5</issue>):<fpage>488</fpage>–<lpage>493</lpage>.</citation>
         </ref>
         <ref id="bibr118-0885066611411408">
            <label>118</label>
            <citation citation-type="journal" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">ACOG Committee Opinion</collab>. <article-title>Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy</article-title>. <source>Obstet Gynecol</source>. <year>2004</year>;<volume>104</volume>(<issue>3</issue>):<fpage>647</fpage>–<lpage>651</lpage>.</citation>
         </ref>
      </ref-list>
   </back>
</article>